Publications and communications of Hustinx, Roland

Kirienko, M., Telo, S., HUSTINX, R., Bomanji, J. B., Chiti, A., & Fanti, S. (January 2022). The Impact of COVID-19 on Nuclear Medicine in Europe. Seminars in Nuclear Medicine, 52 (1), 17-24. doi:10.1053/j.semnuclmed.2021.06.022

Sanz, L.* , Szymkowicz, E.* , Lejeune, N., Bonin, E., Sala, A., Panda, R., Thibaut, A., Dardenne, N., Dikenstein, D., Van Goethem, S., LEDOUX, D., HUSTINX, R., LAUREYS, S., & Gosseries, O. (2022). Investigation of apomorphine-related neural mechanisms in severe brain-injured patients with prolonged disorders of consciousness. Paper presented at 25th annual meeting of the ASSC, Amsterdam, Netherlands.

Ibrahim, A., Widaatalla, Y., Refaee, T., Primakov, S., Miclea, R. L., Öcal, O., Fabritius, M. P., Ingrisch, M., Ricke, J., HUSTINX, R., Mottaghy, F. M., Woodruff, H. C., Seidensticker, M., & Lambin, P. (16 September 2021). Reproducibility of CT-Based Hepatocellular Carcinoma Radiomic Features across Different Contrast Imaging Phases: A Proof of Concept on SORAMIC Trial Data. Cancers, 13 (18), 4638. doi:10.3390/cancers13184638

Frix, A.-N., COUSIN, F., Refaee, T., Bottari, F., Vaidyanathan, A., DESIR, C., Vos, W., Walsh, S., Occhipinti, M., LOVINFOSSE, P., Leijenaar, R. T. H., HUSTINX, R., MEUNIER, P., LOUIS, R., Lambin, P., & GUIOT, J. (25 June 2021). Radiomics in Lung Diseases Imaging: State-of-the-Art for Clinicians. Journal of Personalized Medicine, 11 (7), 602. doi:10.3390/jpm11070602

Ibrahim, A., Refaee, T., Primakov, S., Barufaldi, B., Acciavatti, R. J., Granzier, R. W. Y., HUSTINX, R., Mottaghy, F. M., Woodruff, H. C., Wildberger, J. E., Lambin, P., & Maidment, A. D. A. (21 June 2021). Reply to Orlhac, F.; Buvat, I. Comment on "Ibrahim et al. The Effects of In-Plane Spatial Resolution on CT-Based Radiomic Features' Stability with and without ComBat Harmonization. Cancers 2021, 13, 1848". Cancers, 13 (12), 3080. doi:10.3390/cancers13123080

Ibrahim, A., Refaee, T., Leijenaar, R. T. H., Primakov, S., HUSTINX, R., Mottaghy, F. M., Woodruff, H. C., Maidment, A. D. A., & Lambin, P. (07 May 2021). The application of a workflow integrating the variable reproducibility and harmonizability of radiomic features on a phantom dataset. PLoS ONE, 16 (5), 0251147. doi:10.1371/journal.pone.0251147

Aerts, A., Eberlein, U., Holm, S., Hustinx, R., Konijnenberg, M., Strigari, L., van Leeuwen, F. W. B., Glatting, G., & Lassmann, M. (2021). EANM position paper on the role of radiobiology in nuclear medicine. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05345-9

Bastin, C., Bahri, M. A., BERNARD, C., HUSTINX, R., & Salmon, E. (2021). Frontal hypometabolism in neurocognitive disorder with behavioral disturbance. The Journal of Nuclear Medicine.

COUSIN, F., DESIR, C., BEN MUSTAPHA, S., MIEVIS, C., Coucke, P., & Hustinx, R. (2021). Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 157, 47-55. doi:10.1016/j.radonc.2021.01.001

Da Silva Ferreira, M., LOVINFOSSE, P., HERMESSE, J., DE CUYPERE, M., Rousseau, C., Lucia, F., Schick, U., Reinhold, C., Robin, P., Hatt, M., Visvikis, D., Bernard, C., Leijenaar, R. T. H., Kridelka, F., Lambin, P., Meyer, P., & Hustinx, R. (2021). [(18)F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05303-5

Guiot, J., Vaidyanathan, A., DEPREZ, L., Zerka, F., Danthine, D., Frix, A.-N., Lambin, P., Bottari, F., Tsoutzidis, N., Miraglio, B., Walsh, S., Vos, W., Hustinx, R., Ferreira, M., LOVINFOSSE, P., & Leijenaar, R. T. H. (2021). A review in radiomics: Making personalized medicine a reality via routine imaging. Medicinal Research Reviews. doi:10.1002/med.21846

Iantsen, A., Da Silva Ferreira, M., Lucia, F., Jaouen, V., Reinhold, C., Bonaffini, P., Alfieri, J., Rovira, R., Masson, I., Robin, P., Mervoyer, A., Rousseau, C., Kridelka, F., DE CUYPERE, M., LOVINFOSSE, P., Pradier, O., Hustinx, R., Schick, U., Visvikis, D., & Hatt, M. (2021). Convolutional neural networks for PET functional volume fully automatic segmentation: development and validation in a multi-center setting. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05244-z

Ibrahim, A., Refaee, T., Primakov, S., Barufaldi, B., Acciavatti, R. J., Granzier, R. W. Y., Hustinx, R., Mottaghy, F. M., Woodruff, H. C., Wildberger, J. E., Lambin, P., & Maidment, A. D. A. (2021). The Effects of In-Plane Spatial Resolution on CT-Based Radiomic Features' Stability with and without ComBat Harmonization. Cancers, 13 (8). doi:10.3390/cancers13081848

Konijnenberg, M., Herrmann, K., Kobe, C., Verburg, F., Hindorf, C., Hustinx, R., & Lassmann, M. (2021). EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy. European Journal of Nuclear Medicine and Molecular Imaging, 48 (1), 67-72. doi:10.1007/s00259-020-05038-9

LOVINFOSSE, P., Hustinx, R., & Couturier, O.-F. (2021). TEP/TDM multi-phase: revue de la littérature. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique. doi:10.1016/j.mednuc.2021.02.002

LOVINFOSSE, P., Weekers, F., Pottel, H., BOUQUEGNEAU, A., BONVOISIN, C., BOVY, C., GROSCH, S., Hustinx, R., & Jouret, F. (2021). [(18)F]FDG PET/CT imaging disproves renal allograft acute rejection in kidney transplant recipients with acute kidney dysfunction: a validation cohort. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05467-0

Matassa, G., Gelardi, F., Hustinx, R., & Chiti, A. (2021). Highlights of 33rd EANM Annual Congress 2020, virtual edition. European Journal of Nuclear Medicine and Molecular Imaging, 1-5. doi:10.1007/s00259-021-05366-4

Rinkin, C., Fosse, P., MALAISE, O., Chapelier, N., Horrion, J., Seidel, L., Albert, A., Hustinx, R., & Malaise, M. (2021). Dissociation between 2-[(18)F]fluoro-2-deoxy-D-glucose positron emission computed tomography, ultrasound and clinical assessments in patients with non-severe rheumatoid arthritis, including remission. BMC Rheumatology, 5 (1), 31. doi:10.1186/s41927-021-00196-1

Slart, R. H. J. A., Williams, M. C., Juarez-Orozco, L. E., Rischpler, C., Dweck, M. R., Glaudemans, A. W. J. M., Gimelli, A., Georgoulias, P., Gheysens, O., Gaemperli, O., Habib, G., Hustinx, R., Cosyns, B., Verberne, H. J., Hyafil, F., Erba, P. A., Lubberink, M., Slomka, P., Išgum, I., & Saraste, A. (2021). Position paper of the EACVI and EANM on artificial intelligence applications in multimodality cardiovascular imaging using SPECT/CT, PET/CT, and cardiac CT. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05341-z

GERARD, C., RINKIN, C., Lamaye, C., SEIDEL, L., HUSTINX, R., Malaise, M., & MALAISE, O. (December 2020). Les recommandations « ostéoporose » SFR 2018 identifient une population de polyarthrites rhumatoïdes avec une activité plus élevée et une micro-architecture osseuse (Hr-pQCT) moins bonne : étude de l’influence de la maladie sur les paramètres osseux. Revue du Rhumatisme, 87 (S1), 226. doi:10.1016/j.rhum.2020.10.400

Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., KOOPMANSCH, B., MacKay, G. M., Chiavarina, B., Costanza, B., Rademaker, G., Durieux, F., Agirman, F., Maloujahmoum, N., Cusumano, P. G., LOVINFOSSE, P., Leung, H. Y., LAMBERT, F., Bours, V., & Bellahcene, A. (04 February 2020). Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab. Cell Reports, 30 (5), 1400-1416.e6. doi:10.1016/j.celrep.2020.01.012

CHARLIER, E.* , DEROYER, C.* , NEUVILLE, S., Plener, Z., MALAISE, O., Ciregia, F., Gillet, P., Reuter, G., Salvé, M., Withofs, N., Hustinx, R., de Seny, D., & Malaise, M. (2020). Toward diagnostic relevance of the α(V)β(5), α(V)β(3), and α(V)β(6) integrins in OA: expression within human cartilage and spinal osteophytes. Bone Research, 8, 35. doi:10.1038/s41413-020-00110-4

DE CUYPERE, M., Lovinfosse, P., Gennigens, C., HERMESSE, J., Rovira, R., Duch, J., GOFFIN, F., Hustinx, R., & Kridelka, F. (2020). Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict survival in patients with locally advanced cervical cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 0, 1-8. doi:10.1136/ijgc-2020-001676

DE CUYPERE, M., LOVINFOSSE, P., GOFFIN, F., Gennigens, C., Rovira, R., Duch, J., Fastrez, M., Gebhart, G., Squifflet, J. L., Luyckx, M., Charaf, G., Crener, K., Buxant, F., Bucella, D., Jouret, M., Hustinx, R., & Kridelka, F. (2020). Added value of para-aortic surgical staging compared to (18)F-FDG PET/CT on the external beam radiation field for patients with locally advanced cervical cancer: An ONCO-GF study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. doi:10.1016/j.ejso.2019.11.496

Derwael, C., Lavergne, O., LOVINFOSSE, P., Nechifor, V., Salvé, M., Waltregny, D., Hustinx, R., & WITHOFS, N. (2020). Interobserver agreement of [(68)Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer. EJNMMI Research, 10 (1), 15. doi:10.1186/s13550-020-0596-4

Ibrahim, A., Primakov, S., Beuque, M., Woodruff, H. C., Halilaj, I., Wu, G., Refaee, T., Granzier, R., Widaatalla, Y., Hustinx, R., Mottaghy, F. M., & Lambin, P. (2020). Radiomics for precision medicine: Current challenges, future prospects, and the proposal of a new framework. Methods (San Diego, Calif.). doi:10.1016/j.ymeth.2020.05.022

JADOUL, A., Bernard, C., LOVINFOSSE, P., GERARD, L., LILET, H., Cornet, O., & Hustinx, R. (2020). Comparative dosimetry between (99m)Tc-MAA SPECT/CT and (90)Y PET/CT in primary and metastatic liver tumors. European Journal of Nuclear Medicine and Molecular Imaging, 47 (4), 828-837. doi:10.1007/s00259-019-04465-7

JADOUL, A., LOVINFOSSE, P., BOUQUEGNEAU, A., WEEKERS, L., Pottel, H., Hustinx, R., & Jouret, F. (2020). Observer variability in the assessment of renal (18)F-FDG uptake in kidney transplant recipients. Scientific Reports, 10 (1), 4617. doi:10.1038/s41598-020-61032-z

Meyers, N., JADOUL, A., BERNARD, C., DELWAIDE, J., LAMPROYE, A., DETRY, O., HONORE, P., GERARD, L., & HUSTINX, R. (2020). Inter-observer variability of 90Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization. EJNMMI Research. doi:10.1186/s40658-020-00302-1

Mirzaei, S., Hustinx, R., Prior, J. O., Ozcan, Z., Boubaker, A., Farsad, M., & European Union of Medical Specialists and European Board for Nuclear Medicine. (2020). Improving Nuclear Medicine Practice with UEMS/EBNM Committees. Journal of Nuclear Medicine, 61 (3), 18N-20.

Neuville, M., LOVINFOSSE, P., JADOUL, A., THYS, M., SEIDEL, L., Hustinx, R., & Jouret, F. (2020). The use of a visual 4-point scoring scale improves the yield of (18)F-FDG PET-CT imaging in the diagnosis of renal and hepatic cyst infection in patients with autosomal dominant polycystic kidney disease. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-020-04903-x

Da Silva Ferreira, M., LOVINFOSSE, P., DE CUYPERE, M., Rovira, R., Lucia, F., Schick, U., Vallières, M., Bonaffini, P., Reinhold, C., Visvikis, D., Hatt, M., BERNARD, C., Leijenaar, R., Walsh, S., KRIDELKA, F., Meyer, P., & HUSTINX, R. (29 November 2019). FDG PET radiomics to predict disease free survival in Cervical Cancer. Paper presented at Bioforum Liege 2019.

Da Silva Ferreira, M., LOVINFOSSE, P., DE CUYPERE, M., Rovira, R. R., Lucia, F., Schick, U., Vallières, M., Bonaffini, P., Reinhold, C., Visvikis, D., Hatt, M., BERNARD, C., Leijenaar, R., Walsh, S., KRIDELKA, F., Meyer, P., & HUSTINX, R. (02 November 2019). FDG PET radiomics to predict disease free survival in Cervical Cancer. Paper presented at 2019 IEEE Nuclear Science Symposium & Medical Imaging Conference.

Da Silva Ferreira, M., LOVINFOSSE, P., DE CUYPERE, M., Rovira, R., Lucia, F., Schick, U., Vallières, M., Bonaffini, P., Reinhold, C., Visvikis, D., Hatt, M., BERNARD, C., Leijenaar, R., Walsh, S., KRIDELKA, F., Meyer, P., & HUSTINX, R. (September 2019). Radiomics for Disease Free Survival prediction using pre-treatment FDG PET images. Paper presented at "Imaging of diagnostic and therapeutic biomarkers in Oncology“ workshop Manoir de Kerdréan, Le Bono, France, September 25th- 28th, 2019.

Charlier, E., NEUVILLE, S., PLENER, Z., DEROYER, C., RELIC, B., MALAISE, O., REUTER, G., GILLET, P., Salvé, M., WITHOFS, N., HUSTINX, R., DE SENY, D., & MALAISE, M. (May 2019). EXPRESSION OF αVβ5, αVβ3 AND β6 INTEGRINS BY OSTEOARTHRITIC CHONDROCYTES AND VERTEBRAL OSTEOPHYTES. Poster session presented at OARSI, Toronto, Canada.

COURTOIS, A., MAKRYGIANNIS, G., El hachemi, M., Hultgren, R., Allaire, E., Namur, G., HUSTINX, R., DEFRAIGNE, J., & SAKALIHASAN, N. (2019). Positron Emission Tomography/Computed Tomography Predicts and Detects Complications After Endovascular Repair of Abdominal Aortic Aneurysms. Journal of Endovascular Therapy. doi:10.1177/1526602819849088

HANSSEN, O., LOVINFOSSE, P., WEEKERS, L., Hustinx, R., & Jouret, F. (2019). La tomographie par emission de positons au 18F-FDG en pathologie renale non oncologique : indications actuelles et perspectives. Nephrologie & therapeutique. doi:10.1016/j.nephro.2018.11.007

Hanssen, O., Weekers, L., Lovinfosse, P., Jadoul, A., Bonvoisin, C., Bouquegneau, A., Grosch, S., Huynen, A., Anglicheau, D., Hustinx, R., & Jouret, F. (2019). Diagnostic yield of (18) F-FDG PET/CT imaging and urinary CXCL9/creatinine levels in kidney allograft subclinical rejection. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. doi:10.1111/ajt.15742

Hustinx, R. (2019). Physician centred imaging interpretation is dying out - why should I be a nuclear medicine physician? European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-019-04371-y

Ibrahim, A., Vallières, M., Woodruff, H., Primakov, S., Beheshti, M., Keek, S., Refaee, T., Sanduleanu, S., Walsh, S., Morin, O., Lambin, P., HUSTINX, R., & Mottaghy, F. M. (2019). Radiomics Analysis for Clinical Decision Support in Nuclear Medicine. Seminars in Nuclear Medicine. doi:10.1053/j.semnuclmed.2019.06.005

LOVINFOSSE, P., Hustinx, R., WEEKERS, L., Jouret, F., & DETRY, O. (2019). The role of FDG PET in detecting rejection after liver transplantation [letter to the editor]. Surgery, 165, 853. doi:10.1016/j.surg.2018.06.014

Meyer, F., Wehenkel, M., Phillips, C., Geurts, P., HUSTINX, R., Bernard, C., Bastin, C., Salmon, E., & Alzheimer's Disease NeuroImaging Initiative. (2019). Characterization of a temporoparietal junction subtype of Alzheimer’s disease. Human Brain Mapping, 40, 4279-4286. doi:10.1002/hbm.24701

Schielke, A. A., MEURISSE, N., LAMPROYE, A., Honoré, P., Delwaide, J., Hustinx, R., & DETRY, O. (2019). Selection criteria for liver transplantation in patients with hepatocellular carcinoma. Eastern and western experiences, and perspectives for the future. Acta Gastro-Enterologica Belgica, 82 (2), 314-318.

WITHOFS, N., Beguin, Y., COUSIN, F., Tancredi, T., SIMONI, P., Alvarez-Miezentseva, V., DE PRIJCK, B., HAFRAOUI, K., Bonnet, C., Baron, F., Hustinx, R., & Caers, J. (2019). Dual-tracer PET/CT scan after injection of combined [ 18 F]NaF and [ 18 F]FDG outperforms MRI in the detection of myeloma lesions. Hematological Oncology, 37, 193-201. doi:10.1002/hon.2600

LOVINFOSSE, P., HATT, M., VISIKIS, D., & HUSTINX, R. (2018). Heterogeneity analysis of 18F‑FDG PET imaging in oncology: clinical indications and perspectives. Clinical and Translational Imaging. doi:10.1007/s40336-018-0299-2

LOVINFOSSE, P., VISVIKIS, D., HUSTINX, R., & HATT, M. (2018). FDG PET radiomics: a review of the methodological aspects. Clinical and Translational Imaging. doi:10.1007/s40336-018-0292-9

Cambier, A., LEONARD, P., Losson, B., GIOT, J.-B., BLETARD, N., Meunier, P., Hustinx, R., MEURISSE, N., Delwaide, J., Honoré, P., Hayette, M.-P., & Detry, O. (June 2018). Alveolar echinococcosis in southern Belgium: retrospective experience of a tertiary center. European Journal of Clinical Microbiology and Infectious Diseases, 37 (6), 1195-1196. doi:10.1007/s10096-018-3233-7

Bakker, J., Balthazart, J., Baron, F., Beguin, Y., Bettendorff, L., Blanpain, C., Bureau, F., Caers, J., Cani, P., Cataldo, D., Cornil, C., Clercx, C., Cloots, R., Colige, A., Daube, G., De Backer, O., de Kerchove d'Exaerde, A., Desmecht, D., Desmet, C., & Wittamer, V. (2018). La souris, le patient, et le faux expert. Décryptage d'une mystification. Le Vif. L'Express.

Rademaker, G., Hennequière, V., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (April 2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Oncogene, 37 ((32)), 4398-4412. doi:10.1038/s41388-018-0287-z

Blomme, A., van Simaeys, G., Doumont, G., Costanza, B., Bellier, J., Otaka, Y., Sherer, F., LOVINFOSSE, P., Boutry, S., Palacios, A. P., De Pauw, E., Hirano, T., Yokobori, T., Hustinx, R., Bellahcene, A., Delvenne, P., DETRY, O., Goldman, S., Nishiyama, M., & Turtoi, A. (March 2018). Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases. Oncogene, 37 (9), 1237-1250. doi:10.1038/s41388-017-0018-x

Cambier, A., GIOT, J.-B., LEONARD, P., BLETARD, N., Meunier, P., Hustinx, R., Delwaide, J., MEURISSE, N., Honoré, P., Losson, B., Hayette, M.-P., & Detry, O. (March 2018). Prise en charge multidisciplinaire de l'echinococcose alveolaire : le groupe Echino-Liege. Revue Médicale de Liège, 73 (3), 135-142.

Salvé, M., Avohou, T. H., Monbaliu, J.-C., Lebrun, P., Lemaire, C., Damblon, C., De Tullio, P., Hubert, P., Hustinx, R., & Luxen, A. (12 February 2018). NOTA‐PRGD2 and NODAGA‐PRGD2: Bioconjugation, characterization, radiolabelling, and design space. Journal of Labelled Compounds and Radiopharmaceuticals, 61, 487-500. doi:10.1002/jlcr.3613

Cambier, A., Leonard, P., Losson, B., HAYETTE, M.-P., GIOT, J.-B., BLETARD, N., MEUNIER, P., HUSTINX, R., MEURISSE, N., DELWAIDE, J., Honoré, P., & DETRY, O. (January 2018). Alveolar echinococcosis is now endemic in southern Belgium. Acta Gastro-Enterologica Belgica, 81 (1), 31.

Fosse, P., KAISER, M.-J., Namur, G., DE SENY, D., Malaise, M., & Hustinx, R. (2018). (18)F- FDG PET/CT joint assessment of early therapeutic response in rheumatoid arthritis patients treated with rituximab. European Journal of Hybrid Imaging, 2 (1), 6. doi:10.1186/s41824-017-0022-y

HUSTINX, R. (2018). Apport de la Médecine nucléaire dans l'évaluation du dommage corporel : Consilio Manuque. Revue Belge du Dommage Corporel et de Médecine Légale: Consilio Manuque, 2018/2, 55-62.

LOVINFOSSE, P., POLUS, M., VAN DAELE, D., Martinive, P., DAENEN, F., Hatt, M., Visvikis, D., KOOPMANSCH, B., LAMBERT, F., COIMBRA MARQUES, C., SEIDEL, L., Albert, A., Delvenne, P., & Hustinx, R. (2018). FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-017-3855-5

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., Bellier, J., Costanza, B., Herfs, M., Bettendorff, L., Deroanne, C., Delvenne, P., HUSTINX, R., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma and affects tumor aggressiveness. Poster session presented at Bioforum Uliège.

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Anania, S., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., HUSTINX, R., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic cancer and affects tumor aggressiveness. Poster session presented at Belgian Association for Cancer Research Congress.

Amorim, C., Andris, F., Arckens, L., Arnould, T., Aron, S., Bakker, J., Balligand, M., Balthazart, J., Baron, F., Beck, B., Beguin, Y., Behets, C., Bellefroid, E., Bertrand, L., Bettendorff, L., Bindels, L., Blankert, B., Blanpain, C., Bondue, A., & Wittamer, V. (2017). L’expérimentation animale reste indispensable (OPINION). La Libre Belgique.

HUSTINX, R. (October 2017). Le diagnostic de l'embolie pulmonaire. Pangea-ePatient, 1 (1), p. 29-31.

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (22 September 2017). Myoferlin controls mitochondrial structure in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Poster session presented at Second U-CRC Symposium, Bruxelles, Belgium.

GANGOLF, M., DELGAUDINE, M., JACQUES, J., HUSTINX, R., KOLH, P., MEUNIER, P., VACCARELLA, S. (Other coll.), & LENAERTS, E. (Other coll.). (09 September 2017). Conception d’un tableau de bord stratégique : Application à l’activité du service de Radiodiagnostic du CHU de Liège. Paper presented at 28ème Congrès ALASS - Association Latine pour l'Analyse des Systèmes de Santé, Liège, Belgium.

MARCHETTA, S., WITHOFS, N., ERBA, P. A., HABIB, G., HUSTINX, R., & LANCELLOTTI, P. (August 2017). RADIONUCLIDE IMAGING OF INFECTIVE ENDOCARDITIS: state of art and future perspective. Current Cardiovascular Imaging Reports, 10 (27). doi:10.1007/s12410-017-9425-1

CHARLIER, E., NEUVILLE, S., RELIC, B., DEROYER, C., MALAISE, O., KURTH, W., GILLET, P., WITHOFS, N., HUSTINX, R., DE SENY, D., & MALAISE, M. (April 2017). Regulation of αVβ3 and αVβ5 integrin complexes by osteogenic differentiation of human hip OA chondrocytes. Poster session presented at 2017 World Congress on Osteoarthritis.

Liu, W., Delwaide, J., BLETARD, N., Delvenne, P., Meunier, P., Hustinx, R., & Detry, O. (April 2017). 18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case report. World Journal of Hepatology, 9 (11), 562-566. doi:10.4254/wjh.v9.i11.562

BRULS, S., Courtois, A., DELVENNE, P., HUSTINX, R., MOUTSCHEN, M., de Leval, L., Defraigne, J.-O., & SAKALIHASAN, N. (2017). IgG4-related disease causing rapid evolution of a severe aortic valvular stenosis. Annals of Thoracic Surgery. doi:10.1016/j.athoracsur.2016.08.045

Chiavarina, B., Nokin, M.-J., Bellier, J., Durieux, F., BLETARD, N., Sherer, F., LOVINFOSSE, P., Peulen, O., Verset, L., Dehon, R., Demetter, P., Turtoi, A., Uchida, K., Goldman, S., Hustinx, R., Delvenne, P., Castronovo, V., & Bellahcene, A. (2017). Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer. International Journal of Molecular Sciences, 18 (1). doi:10.3390/ijms18010213

Courtois, A., Nusgens, B., Garbacki, N., HUSTINX, R., Gomez, P., Defraigne, J.-O., Colige, A., & SAKALIHASAN, N. (2017). Circulating microRNAs signature correlates with positive [18F]fluorodeoxyglucose-positron emission tomography in patients with abdominal aortic aneurysm. Journal of Vascular Surgery. doi:10.1016/j.jvs.2016.12.112

Erpicum, P., HANSSEN, O., WEEKERS, L., LOVINFOSSE, P., Meunier, P., TSHIBANDA, L., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (2017). Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients, part II: omics analyses of urine and blood samples. NDT Plus, 1-10. doi:10.1093/ckj/sfw077

Frangos, S., Hustinx, R., Boubaker, A., Varetto, T., Prior, J. O., Siroos, M., & Maffioli, L. (2017). The future of the past is the present. The challenge to educate Nuclear Medicine Specialist in present time. The important role of UEMS Section and European Board of Nuclear Medicine. Journal of Nuclear Medicine. doi:10.2967/jnumed.117.206052

HANSSEN, O., Erpicum, P., LOVINFOSSE, P., Meunier, P., WEEKERS, L., TSHIBANDA, L., Krzesinski, J.-M., HUSTINX, R., & Jouret, F. (2017). Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods. Clinical Kidney Journal, 10 (1), 97-105. doi:10.1093/ckj/sfw062

JODOGNE, S., LENAERTS, E., MARQUET, L., ERPICUM, C., GREIMERS, R., GILLET, P., HUSTINX, R., & DELVENNE, P. (2017). Open Implementation of DICOM for Whole-Slide Microscopic Imaging. In Proceedings,- 12th International Joint Conference on Computer Vision, Imaging and Computer Graphics Theory and Applications (Volume 6) (pp. 81-87). doi:10.5220/0006155100810087

LOVINFOSSE, P., & HUSTINX, R. (2017). Nuclear Medicine techniques in transplantation. Clinical and Translational Imaging. doi:10.1007/s40336-016-0216-5

MAGIS, D., D'Ostilio, K., Thibaut, A., De Pasqua, V., GERARD, P., HUSTINX, R., LAUREYS, S., & SCHOENEN, J. (2017). Cerebral metabolism before and after external trigeminal nerve stimulation in episodic migraine. Cephalalgia. doi:10.1177/0333102416656118

Thibaut, A., Moissenet, F., Di Perri, C., Schreiber, C., Remacle, A., Kolanowski, E., CHANTRAINE, F., BERNARD, C., HUSTINX, R., Tshibanda, J.-F., Filipetti, P., Laureys, S., & Gosseries, O. (2017). Brain plasticity after implanted peroneal nerve electrical stimulation to improve gait in chronic stroke patients: Two case reports. NeuroRehabilitation, 40 (2), 251-258. doi:10.3233/NRE-161410

WITHOFS, N., COUSIN, F., DE PRIJCK, B., Bonnet, C., Hustinx, R., Gambhir, S. S., Beguin, Y., & Caers, J. (2017). A First Report on [(18)F]FPRGD2 PET/CT Imaging in Multiple Myeloma. Contrast Media and Molecular Imaging, 2017, 6162845. doi:10.1155/2017/6162845

Verger, E., Drion, P., MEFFRE, G., BERNARD, C., Duwez, L., Lepareur, N., Couturier, O., Hindré, F., HUSTINX, R., & Lacoeuille, F. (2016). 68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies. PLoS ONE. doi:10.1371/journal.pone.0164626

PAQUES, F., HAMOIR, E., LOVINFOSSE, P., HUSTINX, R., & WITHOFS, N. (2016). A case of added value of 123I-mIBG SPECT/CT imaging in the diagnosis of a pheochromocytoma extending into the left adrenal vein. Acta Chirurgica Belgica. doi:10.1080/00015458.2016.1240917

NEUVILLE, M., Hustinx, R., JACQUES, J., Krzesinski, J.-M., & Jouret, F. (2016). Diagnostic Algorithm in the Management of Acute Febrile Abdomen in Patients with Autosomal Dominant Polycystic Kidney Disease. PLoS ONE. doi:10.1371/journal.pone.0161277

WITHOFS, N., COUSIN, F., TANCREDI, T., SIMONI, P., DE PRIJCK, B., HAFRAOUI, K., BONNET, C., HUSTINX, R., BEGUIN, Y., & CAERS, J. (14 June 2016). Comparison of combined whole-body 18F-NAF and 18F-FDG PET/CT versus MRI for the detection of myeloma lesions. Paper presented at SNMMI 2016 Annual Meeting.

Annen, J.* , Heine, L.* , Ziegler, E., Frasso, G., Bahri, M. A., Di Perri, C., Stender, J., Martial, C., Wannez, S., D'Ostilio, K., Amico, E., Antonopoulos, G., BERNARD, C., TSHIBANDA, L., HUSTINX, R., & Laureys, S. (06 June 2016). Function–structure connectivity in patients with severe brain injury as measured by MRI-DWI and FDG-PET. Human Brain Mapping, 37 (11), 3707-3720. doi:10.1002/hbm.23269

Neuville, M., Hustinx, R., JACQUES, J., Krzesinski, J.-M., & Jouret, F. (23 May 2016). Diagnostic Management of Suspected Acute Cyst Complication in Patients with Autosomal Dominant Polycystic Kidney Disease. Poster session presented at 53 rd congress ERA-EDTA, Vienna, Austria.

Verger, E., Drion, P., MEFFRE, G., BERNARD, C., Bouvier, A., Lepareur Nicolas, Couturier, O., Hindré, F., HUSTINX, R., & Lacoeuille, F. (May 2016). Microparticules à base d’amidon radiomarquées au 188Re et 68Ga comme agent théranostique pour la radiothérapie interne sélective du carcinome hépatocellulaire. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 40 (3), 182. doi:10.1016/j.mednuc.2016.03.035

Verger, E., Drion, P., MEFFRE, G., BERNARD, C., Duwez, L., Lepareur, N., Couturier, O., Hindré, F., Lacoeuille, F., & HUSTINX, R. (01 May 2016). 188Re and 68Ga radiolabeled Starch-Based Microparticles as potential theranostic radiopharmaceutical for Hepatocellular Carcinoma. Journal of Nuclear Medicine, 57 (suppl. 2).

Jadoul, A., LOVINFOSSE, P., WEEKERS, L., DELANAYE, P., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (28 April 2016). The Uptake of 18F-FDG by Renal Allograft in Kidney Transplant Recipients is not Influenced by Renal Function. Paper presented at Annual Meeting of the BVN-SBN, Bruxelles, Belgium.

Cottereau, A. S., Becker, S., Broussais, F., Casasnovas, O., Kanoun, S., Roques, M., Charrier, N., Bertrand, S., Delarue, R., Bonnet, C., Hustinx, R., Gaulard, P., de Leval, L., Vera, P., Itti, E., Mounier, N., Haioun, C., Tilly, H., & Meignan, M. (April 2016). Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)†. Annals of Oncology, 27, 719-724. doi:10.1093/annonc/mdw011

WITHOFS, N., & HUSTINX, R. (19 February 2016). Integrin αvβ3 and RGD-based radiopharmaceuticals. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 40 (2016), 41-54. doi:10.1016/j.mednuc.2015.12.002

Barrington, S. F., Fosse, P., WITHOFS, N., Itti, E., Hustinx, R., Couturier, O.-F., & Meignan, M. (2016). Recommendations to stage and assess the response to therapy of lymphomas with [18F]FDG-PET-CT. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 40 (1), 55 - 64. doi:10.1016/j.mednuc.2015.12.004

Di Perri, C., Bahri, M. A., Amico, E., Thibaut, A., Heine, L., Antonopoulos, G., Charland-Verville, V., Wannez, S., Gomez, F., HUSTINX, R., TSHIBANDA, L., Demertzi, A.* , Soddu, A.* , & Laureys, S.*. (2016). Neural correlates of consciousness in patients who have emerged from a minimally conscious state: A cross-sectional multimodal imaging study. Lancet Neurology, 15, 830-842. doi:10.1016/S1474-4422(16)00111-3

Hustinx, R. (2016). How to scan who: the delicate balance between selecting the patient and selecting the imaging protocol. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-016-3511-5

JADOUL, A., LOVINFOSSE, P., WEEKERS, L., DELANAYE, P., KRZESINSKI, J.-M., HUSTINX, R., & JOURET, F. (2016). The uptake of 18F-FDG by renal allograft in kidney transplant recipients is not influenced by renal function. Poster session presented at LIII Congress of ERA-EDTA, Vienna, Austria.

Jadoul, A., LOVINFOSSE, P., WEEKERS, L., DELANAYE, P., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (2016). The Uptake of 18F-FDG by Renal Allograft in Kidney Transplant Recipients Is Not Influenced by Renal Function. Clinical Nuclear Medicine, 41 (9), 683-7. doi:10.1097/RLU.0000000000001298

LOVINFOSSE, P., Janvary, Z. L., COUCKE, P., JODOGNE, S., BERNARD, C., Hatt, M., Visvikis, D., JANSEN, N., DUYSINX, B., & HUSTINX, R. (2016). FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-016-3314-8

LOVINFOSSE, P., KOOPMANSCH, B., LAMBERT, F., JODOGNE, S., KUSTERMANS, G., Hatt, M., Visvikis, D., SEIDEL, L., POLUS, M., Albert, A., DELVENNE, P., & HUSTINX, R. (2016). 18F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status. British Journal of Radiology, 20160212. doi:10.1259/bjr.20160212

LOVINFOSSE, P.* , Weekers, L.* , BONVOISIN, C., BOVY, C., GROSCH, S., Krzesinski, J.-M., Hustinx, R., & JOURET, F. (2016). Fluorodeoxyglucose F Positron Emission Tomography Coupled With Computed Tomography in Suspected Acute Renal Allograft Rejection. American Journal of Transplantation. doi:10.1111/ajt.13429

WITHOFS, N., Martinive, P., VANDERICK, J., BLETARD, N., SCAGNOL, I., Mievis, F., Giacomelli, F., Coucke, P., Delvenne, P., Cataldo, D., Gambhir, S. S., & HUSTINX, R. (2016). [18F]FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-015-3219-y

Neuville, M., Hustinx, R., Krzesinski, J.-M., & Jouret, F. (09 October 2015). Diagnostic Management of Suspected Acute Cyst Complication in Patients with Autosomal Dominant Polycystic Kidney Disease. Poster session presented at BENELUX kidney meeting, Eindhoven, Netherlands.

LOVINFOSSE, P., WEEKERS, L., BOVY, C., BONVOISIN, C., GROSCH, S., KRZESINSKI, J.-M., Hustinx, R., & Jouret, F. (13 September 2015). 18FDG-PET/CT IMAGING IN SUSPECTED ACUTE RENAL ALLOGRAFT REJECTION. Paper presented at 17th Congress of the European Society for Organ Transplantation, Brussels, Belgium.

WEEKERS, L., LOVINFOSSE, P., BONVOISIN, C., BOVY, C., GROSCH, S., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (September 2015). Place de la tomographie à émission de positons au 18FDG couplée à la tomodensitométrie en cas de suspicion de rejet aigu du greffon rénal. Néphrologie et Thérapeutique, 11 (5), 280.

Antonopoulos, G., Wannez, S., Thibaut, A., Bahri, M. A., HUSTINX, R., BERNARD, C., Bruno, M.-A., Chatelle, C., Luxen, A., Phillips, C., Maquet, P., & Laureys, S. (22 June 2015). Diagnostic accuracy of cerebral metabolic imaging in disorders of consciousness. Poster session presented at 1st Congress of the European Academy of Neurology 2015, Berlin, Germany.

Wannez, S., Thibaut, A., Vitali-Roscini, G., Di Perri, C., Bruno, M.-A., Chatelle, C., BERNARD, C., HUSTINX, R., MAQUET, P., Majerus, S., & Laureys, S. (21 June 2015). Recovery of language comprehension in the minimally conscious state studied by FDG-PET. Poster session presented at 1st Congress of the European Academy of Neurology, Berlin, Germany.

Antonopoulos, G., Wannez, S., Thibaut, A., Bahri, M. A., HUSTINX, R., Bernard, C., Bruno, M.-A., Chatelle, C., Luxen, A., Phillips, C., & Laureys, S. (17 June 2015). Automatic Classification of FDG-PET imaging data in Disorders of Consciousness. Poster session presented at 21 ST ANNUAL MEETING OF THE ORGANIZATION FOR HUMAN BRAIN MAPPING, Honolulu, Hawaii, United States.

Annen, J., Heine, L., Ziegler, E., Stender, J., Bahri, M. A., Wannez, S., Bruno, M.-A., Thibaut, A., BERNARD, C., Antonopoulos, G., Di Perri, C., Martial, C., Amico, E., Demertzi, A., Salmon, E., Maquet, P., TSHIBANDA, L., HUSTINX, R., & Laureys, S. (June 2015). Multimodal characterization of default mode network structure and metabolism in patients with disorders of consciousness using diffusion weighted-MRI and 18F-FDG-PET. Poster session presented at 1st Congress of the European Academy of Neurology, Berlin, Germany.

DUYSINX, B., & HUSTINX, R. (April 2015). Imagerie métabolique en oncologie thoracique. EMC - Pneumologie, 12 (2).

Detry, O., Govaerts, L., De Roover, A., VANDERMEULEN, M., MEURISSE, N., Malenga, BLETARD, N., Mbendi, C., LAMPROYE, A., Honoré, P., MEUNIER, P., Delwaide, J., & Hustinx, R. (14 March 2015). Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma. World Journal of Gastroenterology, 21 (10), 3049-54. doi:10.3748/wjg.v21.i10.3049

WITHOFS, N., SIGNOLLE, N., SOMJA, J., LOVINFOSSE, P., MUTIJIMA NZARAMBA, E., Mievis, F., Giacomelli, F., WALTREGNY, D., CATALDO, D., GAMBHIR, S. S., & HUSTINX, R. (2015). 18F-FPRGD2 PET/CT imaging of integrin αvβ3 in renal carcinomas: Correlation with histopathology. Journal of Nuclear Medicine. doi:10.2967/jnumed.114.149021

COOK, G., & HUSTINX, R. (2015). Challenges for imaging and therapy of musculoskeletal tumours. Clinical and Translational Imaging. doi:10.1007/s40336-015-0111-5

Bretin, F., Bahri, M. A., BERNARD, C., Warnock, G., Aerts, J., Mestdagh, N., Buchanan, T., Otoul, C., Koestler, F., Mievis, F., Giacomelli, F., Degueldre, C., Hustinx, R., Luxen, A., Seret, A., Plenevaux, A., & Salmon, E. (17 January 2015). Biodistribution and radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H: First-in-human study. Molecular Imaging and Biology, 17, 557-564. doi:10.1007/s11307-014-0820-6

SAKALIHASAN, N., NIENABER, C., HUSTINX, R., LOVINFOSSE, P., EL HACHEMI, M., CHERAMY-BIEN, J.-P., SEIDEL, L., LAVIGNE, J.-P., QUANIERS, J., KERSTENNE, M.-A., Courtois, A., OOMS, A., Albert, A., Defraigne, J.-O., & Michel, J.-B. (2015). (Tissue PET) vascularmetabolic imaging and peripheral plasma biomarkers in the evolution of chronic aortic dissections. European Heart Journal - Cardiovascular Imaging. doi:10.1093/ehjci/jeu283

Barrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Mueller, S., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., Hoekstra, O. S., Hicks, R. J., O'Doherty, M. J., HUSTINX, R., Biggi, A., Cavalli, F., Lister, T. A., & Cheson, B. D. (2015). Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al. Journal of Clinical Oncology, 33 (10), 1221-3. doi:10.1200/JCO.2014.59.9373

Barrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Mueller, S., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., Hoekstra, O. S., Hicks, R. J., O'Doherty, M. J., HUSTINX, R., Biggi, A., & Cheson, B. D. (2015). Reply to G. Keramida et al. Journal of Clinical Oncology, 33 (34), 4121-2. doi:10.1200/JCO.2015.63.2125

Bruls, S.* , Courtois, A.* , Nusgens, B., Defraigne, J.-O., Delvenne, P., Hustinx, R., Moutschen, M., & SAKALIHASAN, N. (2015). 18F-FDG PET/CT in the Management of Aortitis. Clinical Nuclear Medicine. doi:10.1097/RLU.0000000000001016

Courtois, A., Nusgens, B., HUSTINX, R., Defraigne, J.-O., Colige, A., & SAKALIHASAN, N. (2015). Circulating miRNA signature of PET-positive abdominal aortic aneurysms: new potential predictors of rupture. Arteriosclerosis, Thrombosis and Vascular Biology.

Courtois, A., Nusgens, B., HUSTINX, R., Namur, G., Gomez, P., Kuivaniemi, H., Defraigne, J.-O., Colige, A., & SAKALIHASAN, N. (2015). Gene Expression Study in Positron Emission Tomography–Positive Abdominal Aortic Aneurysms Identifies CCL18 as a Potential Biomarker for Rupture Risk. Molecular Medicine. doi:10.2119/molmed.2014.00065

HATT, M., MAJDOUB, M., VALLIERES, M., TIXIER, F., CHEZE LE REST, C., GROHEUX, D., HINDIE, E., MARTINEAU, A., PRADIER, O., HUSTINX, R., PERDRISOT, R., GUILLEVIN, R., EL NAQA, I., & VISVIKIS, D. (January 2015). 18F-FDG PET Uptake Characterization Through Texture Analysis: Investigating the Complementary Nature of Heterogeneite and Functional Tumor Volume in a Multi-Cancer Site Patient Cohort. Journal of Nuclear Medicine, 56 (1), 38-44. doi:10.2967/jnumed.114.144055

PRIGENT, A., HUSTINX, R., & COSTA, D. C. (2015). Nuclear medicine training in the European Union : 2015 Update. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-015-3244-x

Salmon, E., Bernard, C., & HUSTINX, R. (2015). Pitfalls and Limitations of PET/CT in Brain Imaging. Seminars in Nuclear Medicine, 45 (6), 541-51. doi:10.1053/j.semnuclmed.2015.03.008

Stender, J., Kupers, R., Rodell, A., Thibaut, A., Chatelle, C., Bruno, M.-A., Gejl, M., Bernard, C., Hustinx, R., Laureys, S., & Gjedde, A. (2015). Quantitative rates of brain glucose metabolism distinguish minimally conscious from vegetative state patients. Journal of Cerebral Blood Flow and Metabolism, 35 (1), 58-65. doi:10.1038/jcbfm.2014.169

Thibaut, A., Di Perri, C., Chatelle, C., Bruno, M.-A., Bahri, M. A., Wannez, S., Piarulli, A., BERNARD, C., Martial, C., Heine, L., HUSTINX, R., & Laureys, S. (2015). Clinical Response to tDCS Depends on Residual Brain Metabolism and Grey Matter Integrity in Patients With Minimally Conscious State. Brain Stimulation, 8 (6), 1116-23. doi:10.1016/j.brs.2015.07.024

Verger, E., Cikankowitz, A., Bouvier, A., Lepareur, N., Benoit, J.-P., Deloye, J.-B., Aubé, C., Couturier, O., Lacoeuille, F., Hustinx, R., & Hindré, F. (2015). A theranostic tool for Hepatocellular carcinoma: the Starch-Based Microparticles. Paper presented at 3rd Nuclear Technologies for Health Symposium, Nantes, France.

WITHOFS, N., CHARLIER, E., Simoni, P., Alvarez-Miezentseva, V., Mievis, F., Giacomelli, F., Mella, C., Gambhir, S. S., Malaise, O., DE SENY, D., MALAISE, M., & HUSTINX, R. (2015). (18)F-FPRGD2 PET/CT imaging of musculoskeletal disorders. Annals of Nuclear Medicine, 29 (10), 839-47. doi:10.1007/s12149-015-1011-5

JODOGNE, S., LENAERTS, E., COUCKE, P., & HUSTINX, R. (26 November 2014). Orthanc - Free and Open-Source Software for Medical Imaging in Hospitals. Poster session presented at BioWin Day 2014, Louvain-la-Neuve, Belgium.

Verger, E., Bouvier, A., Benoit, J.-P., Aubé, C., Couturier, O., HUSTINX, R., Lacoeuille, F., & Hindré, F. (October 2014). Radiolabelling of starch microparticles with Rhenium-188 for hepatocellular carcinoma’s therapy. European Journal of Nuclear Medicine and Molecular Imaging, 41 (Supplement 2), 443-S444. doi:10.1007/s00259-014-2901-9

MEURISSE, N., DETRY, O., Govaerts, L., DE ROOVER, A., VANDERMEULEN, M., Malenga, S., BLETARD, N., Mbendi, C., LAMPROYE, A., HONORE, P., MEUNIER, P., Delwaide, J., & HUSTINX, R. (September 2014). Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma. Transplant International, 27 (S2), 18 (EP-17.

BARRINGTON, S. F., MIKKHAEEL, N. G., KOSTAKOGLU, L., MEIGNAN, M., HUTCHINGS, M., MUELLER, S. P., SCHWARTZ, L. H., ZUCCA, E., FISHER, R. I., TROTMAN, J., HOEKSTRA, O. S., HICKS, R. J., O'DOHERTY, M. J., HUSTINX, R., BIGGI, A., & CHESON, B. D. (2014). Role of Imaging in the Staging and Response Assessment of Lymphoma : Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. Journal of Clinical Oncology. doi:10.1200/JCO.2013.53.5229

JODOGNE, S., LENAERTS, E., COUCKE, P., & HUSTINX, R. (2014). Orthanc - Logiciel libre pour l'imagerie médicale en milieu hospitalier. In Communications de la Conférence Francophone en Gestion et Ingénierie des Systèmes Hospitaliers (GISEH 2014).

CAERS, J., WITHOFS, N., Hillengass, J., SIMONI, P., Zamagni, E., HUSTINX, R., & BEGUIN, Y. (April 2014). The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow-up of multiple myeloma. Haematologica, 99 (4), 629-37. doi:10.3324/haematol.2013.091918

DETRY, O., Govaerts, L., BLETARD, N., MEURISSE, N., Verset, G., DE ROOVER, A., DELWAIDE, J., LAMPROYE, A., HONORE, P., & HUSTINX, R. (March 2014). Prognostic value of FDG PET/CT in liver transplantation for hepatocarcinoma. Acta Gastro-Enterologica Belgica, 77 (1), 08.

BECKERS, C., & Hustinx, R. (2014). SPECT/CT workflow and imaging protocols. European Journal of Nuclear Medicine and Molecular Imaging, 41, 137-S145. doi:10.1007/s00259-013-2629-y

BISOGNI, C., MEURISSE, M., BETEA, D., & HUSTINX, R. (2014). L'image du mois : une parathyroïde ectopique. Revue Médicale de Liège, 69 (9), 473-475.

Chatelle, C., Thibaut, A., Bruno, M.-A., Boly, M., Bernard, C., Hustinx, R., Schnakers, C., & Laureys, S. (2014). Nociception coma scale-revised scores correlate with metabolism in the anterior cingulate cortex. Neurorehabilitation and Neural Repair, 28 (2), 149-52. doi:10.1177/1545968313503220

Chatelle, C.* , Thibaut, A.* , Gosseries, O., Bruno, M.-A., Demertzi, A., BERNARD, C., HUSTINX, R., TSHIBANDA, L., Bahri, M. A., & Laureys, S. (2014). Changes in cerebral metabolism in patients with a minimally conscious state responding to zolpidem. Frontiers in Neuroscience, 8, 917. doi:10.3389/fnhum.2014.00917

Courtois, A., Namur, G., EL HACHEMI, M., Creemers, E., Nusgens, B., HUSTINX, R., Allaire, E., Defraigne, J.-O., Colige, A., & SAKALIHASAN, N. (2014). Uptake of FDG detected by positron emission tomography in the abdominal aortic aneurysm is correlated with endoleaks and predicts the adverse outcome of AAA after endovascular aortic repair. Poster session presented at 4th International meeting on aortic disease.

Courtois, A., Nusgens, B., Hustinx, R., Defraigne, J.-O., Colige, A., & Sakalihasan, N. (2014). Circulating microRNA expression signature in PET positive abdominal aortic aneurysms: new potential biomarkers. Aorta.

Courtois, A., Nusgens, B., Hustinx, R., Gomez, P., Defraigne, J.-O., Colige, A., & SAKALIHASAN, N. (2014). Intérèts de la tomographie à émission de positons dans le suivi et le pronostic des anévrysmes de l'aorte abdominale. Revue Médicale de Liège, 69 Spec No, 12-8.

DELANAYE, P., BECKERS, C., & HUSTINX, R. (2014). Le néphrogramme isotopique (méthode de “Gates”) permet-il une estimation correcte du débit de filtration glomérulaire ? Revue de la littérature. Poster session presented at XVI réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Saint-Etienne, France.

LALLEMAND, F., LAKOSI, F., HUSTINX, R., WITHOFS, N., MEUNIER, P., TSHIBANDA, L., JODOGNE, S., COUCKE, P., & MARTINIVE, P. (2014). Utilisation de l'imagerie fonctionnelle en radiothérapie. Revue Médicale de Liège, 69 (Supp 1), 20-28.

MEURISSE, N., DETRY, O., GOVAERTS, L., DE ROOVER, A., VANDERMEULEN, M., MALENGA, BLETARD, N., MBENDI, C., LAMPROYE, A., HONORE, P., MEUNIER, P., DELWAIDE, J., & HUSTINX, R. (2014). Prognostic value of 18f-fdg PET - CT in liver transplantation for hepatocarcinoma. Poster session presented at 8 th ELITA ELTR MEETING, Prague, Czechia.

SABOURY, B., SALAVATI, A., BROTHERS, A., BASU, S., KWEE, T., LAM, M., HUSTINX, R., LOUIS, E., TORIGIAN, D., & ALAVI, A. (2014). FDG PET/CT in Crohn's disease : correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity. European Journal of Nuclear Medicine and Molecular Imaging, 41, 605-614. doi:10.1007/s00259-013-2625-2

Stender, J., Kupers, R., Rodell, A., Thibaut, A., Chatelle, C., Bruno, M.-A., Gejl, M., Bernard, C., HUSTINX, R., Laureys, S., & Gjedde, A. (2014). Quantitative rates of brain glucose metabolism distinguish minimally conscious from vegetative state patients. Journal of Cerebral Blood Flow and Metabolism. doi:10.1038/jcbfm.2014.169

Thibaut, A., Chatelle, C., Stender, J., Demertzi, A., BERNARD, C., HUSTINX, R., LAUREYS, S., & Bruno, M.-A. (2014). Positron emission tomography imaging in altered states of consciousness: Coma, sleep and hypnosis. In R. Dierckx, A. Otte, E. Vries, A. Waarde, & K. Leenders (Eds.), PET and SPECT in Neurology (pp. 965-986). Paris, France: Springer.

Verger, E., Bouvier, A., Benoit, J.-P., Couturier, O., HUSTINX, R., Lacoeuille, F., & Hindré, F. (2014). Radiomarquage au 188Re des microparticules à base d’amidon pour la thérapie du carcinome hépatocellulaire. Poster session presented at 8èmes Journées Cancéropole Grand Ouest, Les Sables-d’Olonne, France.

Verger, E., Cikankowitz, A., Bouvier, A., Lepareur, N., Benoit, J.-P., Deloye, J.-B., Aubé, C., Couturier, O., Lacoeuille, F., HUSTINX, R., & Hindré, F. (2014). Starch based microparticles radiolabelling with 99mTc and 188Re for diagnostic and therapy of Hepatocellular carcinoma. Paper presented at 8th International Symposium on Technetium and Rhenium, Pornichet La Baule, France.

Verger, E., Cikankowitz, A., Bouvier, A., Lepareur, N., Benoit, J.-P., Deloye, J.-B., Aubé, C., Couturier, O., Lacoeuille, F., HUSTINX, R., & Hindré, F. (2014). Development of a new selective internal radiation therapy and diagnostic tool for hepatocellular carcinoma: the starch-based microspheres. Poster session presented at 3rd NanoFar Autumn School, Bruxelles, Belgium.

WITHOFS, N., BERNARD, C., VAN DER REST, C., MARTINIVE, P., HATT, M., JODOGNE, S., VISVIKIS, D., LEE, J. A., COUCKE, P., & HUSTINX, R. (2014). FDG PET/CT for rectal carcinoma radiotherapy treatment planning : Comparison of functional volume delineation algorithms and clinical challenges. Journal of Applied Clinical Medical Physics, 15 (5), 216-228. doi:10.1120/jacmp.v15i5.4696

WITHOFS, N., & HUSTINX, R. (2014). Imagerie de l'intégrine αvβ3 par PET/CT au 18F-FPRGD2. Revue Médicale de Liège, 69 (Synthèse 2014), 36-40.

Courtois, A., Nusgens, B., Hustinx, R., Namur, G., Gomez, P., Somja, J., Defraigne, J.-O., Delvenne, P., Michel, J.-B., Colige, A., & Sakalihasan, N. (05 September 2013). 18F-FDG Uptake Assessed by PET/CT in Abdominal Aortic Aneurysms Is Associated with Cellular and Molecular Alterations Prefacing Wall Deterioration and Rupture. Journal of Nuclear Medicine, 54, 1740-1747. doi:10.2967/jnumed.112.115873

GOVAERTS, L., DETRY, O., BLETARD, N., VERSET, G., HONORE, P., DE ROOVER, A., DELWAIDE, J., & HUSTINX, R. (2013). The prognostic value of preoperative FDG PET-CT in hepatocellular carcinoma treated by liver transplantation. In PROCEEDINGS OF THE XVIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.

Charland-Verville, V., Bruno, M.-A., Bahri, M. A., Demertzi, A., Desseilles, M., Chatelle, C., Vanhaudenhuyse, A., HUSTINX, R., BERNARD, C., TSHIBANDA, L., Laureys, S., & Zeman, A. (12 April 2013). Brain dead yet mind alive: A positron emission tomography case study of brain metabolism in Cotard’s syndrome. Cortex: A Journal Devoted to the Study of the Nervous System and Behavior, 49 (7), 1997-1999. doi:10.1016/j.cortex.2013.03.003

Bernard, C., Paulus, C., JODOGNE, S., & Hustinx, R. (2013). Automated platform for the quality control of PET-CT scanners following AFCN/FANC recommendations. In Proceedings of the Belgian Hospital Physicists Association Symposium.

COUSIN, F., Alvarez, V., BECKERS, C., Hustinx, R., & SIMONI, P. (2013). L'image du mois: La myosite ossifiante neurogene. Revue Médicale de Liège, 68 (2), 53-5.

Garraux, G.* , Phillips, C.* , Schrouff, J., Kreisler, A., Lemaire, C., Degueldre, C., Delcour, C., Hustinx, R., Luxen, A., Destée, A., & Salmon, E. (2013). Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes. NeuroImage: Clinical, 2, 883-893. doi:10.1016/j.nicl.2013.06.004

GOVAERTS, L., DETRY, O., BLETARD, N., VERSET, G., HONORE, P., DE ROOVER, A., DELWAIDE, J., & HUSTINX, R. (2013). Prognostic value of FDG PET/CT in patients with hepatocellular carcinoma treated with liver transplantation. European Journal of Nuclear Medicine and Molecular Imaging, 2013 (SUPPL), 287.

Hauzeur, J.-P., Bernard, C., Egrise, D., Kurth, W., Van Cauwenberge, H., LECHANTEUR, C., Gillet, P., Beguin, Y., MALAISE, M., & HUSTINX, R. (2013). (111)Indium-oxine labelling for evaluating the homing process of autologous osteoblasts implanted percutaneously in atrophic nonunion fractures. International Orthopaedics, 37 (1), 131-6. doi:10.1007/s00264-012-1719-y

LOVINFOSSE, P., JANVARY, Z. L., JANSEN, N., DISTER, F., FRUSCH, N., DUYSINX, B., COUCKE, P., & HUSTINX, R. (2013). Prognostic value of FDG PET/CT in patients with lung tumors treated by Cyberknife. Journal of Nuclear Medicine, 54 (SUPPL), 567.

Verger, E., Belloche, C., Cikankowitz, A., Roux, J., Lacoeuille, F., Couturier, O., HUSTINX, R., & Hindré, F. (2013). Nanomedicines and micromedicines for vectorised radiotherapy of Hepatocellular Carcinoma. Poster session presented at 2nd NanoFar Autumn School, Santiago de Compostella, Spain.

Verger, E., Lacoeuille, F., Couturier, O., HUSTINX, R., & Hindré, F. (2013). Nanomédecines et micromédecines pour la radiothérapie vectorisée appliquée au traitement du Carcinome Hepato-Cellulaire. Poster session presented at 7èmes Journées du Cancéropole Grand Ouest, Les Sables d'Olonne, France.

WITHOFS, N., ALVAREZ MIEZENTSEVA, V., SIMONI, P., Luxen, A., GAMBHIR, S., & HUSTINX, R. (2013). Imaging osteoarthritis using (18F)FPRGD2 PET/CT : observation and potential application. Journal of Nuclear Medicine, 54 (SUPPL), 250.

HUSTINX, R. (October 2012). Newer Methods for Improving Yield from FDG-PET Imaging for Accurate Staging, Determining Tumor Biology, and Assessing Prognosis. PET Clinics, 7 (4), 425-430. doi:10.1016/j.cpet.2012.06.005

MAGIS, D., Bruno, M.-A., FUMAL, A., Gerardy, P.-Y., HUSTINX, R., LAUREYS, S., & Schoenen, J. (2012). Cluster headache Award 2012: Central modulation in cluster headache patients treated with occipital nerve stimulation. Journal of Headache and Pain.

VALDES SOCIN, H. G., BISOGNI, C., BETEA, D., Lillet, H., SCAGNOL, I., Hustinx, R., HAMOIR, E., Meurisse, M., & Beckers, A. (2012). Primary hyperparathyroidism confirmed by histology : sensitivity and predictors of 99mTc-Sestamibi/CT scan. In Abstract Book - 13th International Workshop on Multiple Endocrine Neoplasia.

Bruno, M.-A., Majerus, S., Boly, M., Vanhaudenhuyse, A., Schnakers, C., Gosseries, O., Boveroux, P., KIRSCH, M., Demertzi, A., Bernard, C., Hustinx, R., Moonen, G., & Laureys, S. (2012). Functional neuroanatomy underlying the clinical subcategorization of minimally conscious state patients. Journal of Neurology, 259 (6), 1087-98. doi:10.1007/s00415-011-6303-7

Chatelle, C., Thibaut, A., Gosseries, O., Thonnard, M., BERNARD, C., HUSTINX, R., LAUREYS, S., & Bruno, M.-A. (2012). Zolpidem effect on recovery of consciousness: a FDG-PET study. Poster session presented at Belgian Brain Congress, Liège, Belgium.

Govaerts, L., WITHOFS, N., DURIEUX, R., Spote, V., & Hustinx, R. (2012). Acute intramural haematoma of the ascending aorta. European Journal of Nuclear Medicine and Molecular Imaging, 39 (8), 1368-9. doi:10.1007/s00259-012-2130-z

HUSTINX, R. (2012). PET-CT and PET-MRI in Oncology, A practical Guide: Gastrointestinal (135-159). In P. PELLER, R. SUBRAMANIAM, & A. GUERMAZI (Eds.), MEDICAL RADIOLOGY - DIAGNOSIS IMAGING : PET-CT and PET-MRI in Oncology - A pratical Guide (pp. 135-159). Springer. doi:10.1007/174_2011_432

MINON, A., CABAY, J.-E., DEMEZ, P., Bernard, C., MOREAU, P., & HUSTINX, R. (2012). Nodal staging of head and neck squamous cell carcinomas : impact of a dedicated PET/CT protocol. Journal of Nuclear Medicine, 53 (SUPPL), 1354.

Thibaut, A., Bruno, M.-A., Chatelle, C., Gosseries, O., Vanhaudenhuyse, A., Demertzi, A., Schnakers, C., Thonnard, M., CHARLAND-VERVILLE, V., BERNARD, C., Bahri, M. A., Phillips, C., Boly, M., Hustinx, R., & Laureys, S. (2012). Metabolic activity in external and internal awareness networks in severely brain-damaged patients. Journal of Rehabilitation Medicine, 44 (6), 487-94. doi:10.2340/16501977-0940

WITHOFS, N., MARTINIVE, P., SCAGNOL, I., THONON, D., Giacomelli, F., Mievis, F., COUCKE, P., CATALDO, D., Gambhir, S., & HUSTINX, R. (2012). Preliminary results of (18F)FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma. Journal of Nuclear Medicine, 53 (SUPPL), 1703.

WITHOFS, N., SIGNOLLE, N., NZARAMBA, E., THONON, D., LEONARD, M., AERTS, J., WALTREGNY, D., CATALDO, D., GAMBHIR, S., & HUSTINX, R. (2012). (18F)FPRGD2 PET/CT imaging of integrin αvβ3 in renal carcinomas : correlation with histopathology. Journal of Nuclear Medicine, 53 (SUPPL), 1647.

VAN DER REST, C., CAVALIER, E., KAUX, J.-F., KRZESINSKI, J.-M., HUSTINX, R., REGINSTER, J.-Y., & DELANAYE, P. (October 2011). Tumor-induced osteomalacia: The tumor may stay hidden! Clinical Biochemistry, 44 (14-15), 1264-6. doi:10.1016/j.clinbiochem.2011.07.013

VAN DER REST, C., CAVALIER, E., COLSON, L., KAUX, J.-F., KRZESINSKI, J.-M., REGINSTER, J.-Y., HUSTINX, R., & DELANAYE, P. (August 2011). Hypophosphatémie et ostéomalacie oncogénique. Revue Médicale Suisse, 7, 1630-3.

Seret, A., Nguyen, D., HUSTINX, R., & BERNARD, C. (07 May 2011). Potentialités quantitatives et qualité d'image de la camera TEMP/TDM Siemens Symbia T6. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 35, 289.

MAGIS, D., Bruno, M.-A., FUMAL, A., Gerardy, P.-Y., HUSTINX, R., LAUREYS, S., & Schoenen, J. (24 February 2011). Central modulation in cluster headache patients treated with occipital nerve stimulation: an FDG-PET study. BMC Neurology, 11, 25. doi:10.1186/1471-2377-11-25

AGIUS, C., NAMUR, G., COUTURIER, O., & HUSTINX, R. (2011). 2-18F-Fluoro-L-tyrosine in the suspicion of recurrence of previously treated gliomas. European Journal of Nuclear Medicine and Molecular Imaging, 38 (SUPPL), 219.

BERNARD, C., HAUZEUR, J.-P., LECHANTEUR, C., VAN CAUWENBERGE, H., BEGUIN, Y., MALAISE, M., KURTH, W., GILLET, P., & HUSTINX, R. (2011). Evaluation of the homing process in the treatment of atrophic nonunion fractures by percutaneous autologous osteoblast cell implantation. Journal of Nuclear Medicine, 52 (SUPPL), 510.

Bruno, M.-A.* , Gosseries, O.* , Ledoux, D., Hustinx, R., & Laureys, S. (2011). Assessment of consciousness with electrophysiological and neurological imaging techniques. Current Opinion in Critical Care. doi:10.1097/MCC.0b013e328343476d

COURTOIS, A., Nusgens, B., Defraigne, J.-O., Hustinx, R., Gomez, P., Somja, J., Delvenne, P., Colige, A., & SakalihasanN, N. (2011). Uptake of 18-FDG as detected by positron emission tomography is correlated to an increased inflammatory infiltrate and expression of proteolytic enzymes in abdominal aortic aneurysm wall. Poster session presented at The leucocyte in cardiovascular disease conference, Geneva, Switzerland.

Cusumano, P., BLERET, V., Nos, C., Hustinx, R., LILET, H., Gomez, P., & LIFRANGE, E. (2011). Ganglion sentinelle et sentibras: pour un "staging" axillaire sur mesure. Revue Médicale de Liège, 66 (5-6), 336-40.

MINON, A., DEMEZ, P., MOREAU, P., RANSY, P., LEFEBVRE, P., & HUSTINX, R. (2011). Efficacy of FDG PET/CT for diagnosing synchronous tumors and metastases in head and neck tumors : Initial results and evaluation. Journal of Nuclear Medicine, 52 (SUPPL), 1863.

Phillips, C., Bruno, M.-A., Maquet, P., Boly, M., Noirhomme, Q., Schnakers, C., Vanhaudenhuyse, A., Bonjean, M., Hustinx, R., Moonen, G., Luxen, A., & Laureys, S. (2011). "Relevance vector machine" consciousness classifier applied to cerebral metabolism of vegetative and locked-in patients. NeuroImage, 56 (2), 797–808. doi:10.1016/j.neuroimage.2010.05.083

Pourdehnad, M., Basu, S., Duarte, P., Okpaku, A. S., Saboury, B., HUSTINX, R., & Alavi, A. (2011). Reduced grey matter metabolism due to white matter edema allows optimal assessment of brain tumors on 18F-FDG-PET. Hellenic Journal of Nuclear Medicine, 14 (3), 219-23.

SABOURY, B., HUSTINX, R., BROTHERS, B., FOROUGHI, N., HOFHEINZ, F., TARIGIAN, D., & ALAVI, A. (2011). Assessment of Crohn’s disease activity by FDG-PET/CT through a novel quantitative approach. Journal of Nuclear Medicine, 52 (SUPPL), 284.

Thonon, D., Goblet, D., Goukens, E., Kaisin, G., Paris, J., Aerts, J., Lignon, S., Franci, X., Hustinx, R., & Luxen, A. (2011). Fully Automated Preparation and Conjugation of N-Succinimidyl 4-[(18)F]Fluorobenzoate ([ (18)F]SFB) with RGD Peptide Using a GE FASTlab Synthesizer. Molecular Imaging and Biology. doi:10.1007/s11307-011-0470-x

THULKAR, NAMUR, G., HUSTINX, R., BHALLA, A. S., & KUMAR, R. (2011). Multimodality staging of lung cancer. PET Clinics, 6, 251-263. doi:10.1016/j.cpet.2011.05.001

WITHOFS, N., Bernard, C., VAN DER REST, C., MARTINIVE, P., HATT, M., Dimitris, V., COUCKE, P., & HUSTINX, R. (2011). FDG PET/CT for radiotherapy treatment planning. Comparison of functional volume delineation algorithms. Journal of Nuclear Medicine.

WITHOFS, N., COLLIGNON, J., & HUSTINX, R. (2011). Imagerie des métastases osseuses du cancer du sein. Revue Médicale de Liège, 66 (5-6), 291-298.

WITHOFS, N., COLLIGNON, J., RORIVE, A., JERUSALEM, G., & HUSTINX, R. (2011). Hétérogénéité des métastases osseuses du cancer du sein : cas clinique illustrant l'intérêt de combiner différentes techniques d'imagerie. Revue Médicale de Liège, 66 (5-6), 288-290.

Withofs, N., Grayet, B., Tancredi, T., Rorive, A., Mella, C., Giacomelli, F., Mievis, F., Aerts, J., Waltregny, D., Jerusalem, G., & Hustinx, R. (2011). 18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers. Nuclear Medicine Communications, 32 (3), 168-176. doi:10.1097/MNM.0b013e3283412ef5

Bruno, M.-A., Vanhaudenhuyse, A., Schnakers, C., Boly, M., Gosseries, O., Demertzi, A., Majerus, S., Moonen, G., Hustinx, R., & Laureys, S. (2010). Visual fixation in the vegetative state: an observational case series PET study. BMC Neurology, 10, 35. doi:10.1186/1471-2377-10-35

COUCKE, P., WITHOFS, N., JANSEN, N., JANVARY, Z. L., & HUSTINX, R. (2010). Vers une radiothérapie chirurgicale :nécessité d’une radiothérapie guidée par l’imagerie. Revue Médicale de Liège, 65 (supp 1), 17-22.

DEMONTY, J., GONCE, M., Ribai, P., Verellen-Dumoulin, C., & Hustinx, R. (2010). Chorea associated with anti-phospholipid antibodies: case report. Acta Clinica Belgica, 65 (5), 350-3. doi:10.1179/acb.2010.075

Duysinx, B., Corhay, J.-L., Larock, M.-P., Withofs, N., Bury, T., Hustinx, R., & Louis, R. (2010). Contribution of positron emission tomography in pleural disease. Revue des Maladies Respiratoires, 27 (8), 47-53. doi:10.1016/j.rmr.2009.12.003

FOSSE, P., KAISER, M.-J., NAMUR, G., Malaise, M., & HUSTINX, R. (2010). Assessment of early therapeutic response in anti-TNFα refractory rheumatoid arthritis with FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging, 37 (SUPPL), 211.

Hustinx, R., & Beckers, C. (2010). Fluoride PET-CT. In S. Fanti, M. Farsad, & L. Mansi (Eds.), PET-CT Beyond FDG (pp. 64-78). Berlin, Germany: Springer.

HUSTINX, R., & FOSSE, P. (2010). PET in Brain Tumors. In PET clinics 5 (pp. 185-197). Elsevier. doi:10.1016/j.cpet.2010.02.004

Hustinx, R., & Lucignani, G. (2010). PET/CT in head and neck cancer: an update. European Journal of Nuclear Medicine and Molecular Imaging, 37 (3), 645-51. doi:10.1007/s00259-009-1365-9

Magis, D., Bruno, M.-A., Fumal, A., Gérardy, P.-Y., Hustinx, R., Laureys, S., & Schoenen, J. (2010). Central neuromodulation in cluster headache patients treated with occipital nerve stimulators: A PET study. Acta Neurologica Belgica, 110 (Suppl 1), 17.

Nguyen Khac, M.-T., Hustinx, R., Deprez, M., Tshibanda, J., Lefebvre, P., Martin, D., & Robe, P. (21 March 2009). Tumor-like MRS and PET findings in a case of radiation-induced brain necrosis, away from any tumor: an intringuing case report. Paper presented at Réunion annuelle de la Société Belge de Neurochirurgie, LIEGE, Belgium.

Bonnet, C., Beguin, Y., De Prijck, B., Witvrouw, N., Hustinx, R., & Fillet, G. (2009). Les anticorps monoclonaux en hématologie en 2009. Revue Médicale de Liège, 64, 268-273.

Hustinx, R. (2009). Outils isotopiques : TEP et TEP/TDM. In J.-L. Dupas, E. Louis, & P. Marteau, Maladies inflammatoires chroniques de l'intestin (pp. 137-148). Rueil-Malmaison Cedex, France: Wolters Kluwer France.

Hustinx, R., & Louis, E. (2009). The Role of PET/CT in the Monitoring and Diagnosis of Pediatric Inflammatory Bowel Disease. PET Clinics, 3, 597-603. doi:10.1016/j.cpet.2009.04.003

Hustinx, R., & Louis, E. (2009). Outils isotopiques pour les MICI : PET et PET/CT. Côlon et Rectum, 3, 1-7. doi:10.1007/s11725-009-0147-7

RIBBENS, C., & HUSTINX, R. (2009). Nuclear (scintigraphic) methods and FDG-PET in rheumatoid arthritis and osteoarthritis. In M. A. Bruno (Ed.), Arthritis in Color. Advance Imaging of Arthritis. Philadelphia, Unknown/unspecified: Saunders, Elsevier. doi:10.1016/B978-1-4160-4722-3.00007-0

Sakalihasan, N., Hustinx, R., Gomez, P., & Defraigne, J.-O. (2009). Functional imaging of abdominal aortic aneurysms : can it predict probability of rupture. In VASCULAR ANEURYSMS (pp. 91-102). Greece: Ed of University of Thessaly press.

Sakalihasan, N., Hustinx, R., Gomez, P., & Defraigne, J.-O. (2009). Evaluation of inflammatory cells in abdominal aortic aneurysmal wall by tomography emission positron. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 33/5, 279-284. doi:10.1016/j.mednuc.2009.03.002

Schnakers, C., Perrin, F., Schabus, M., Hustinx, R., Majerus, S., Moonen, G., Boly, M., Vanhaudenhuyse, A., Bruno, M.-A., & Laureys, S. (2009). Detecting consciousness in a total Locked-in syndrome: an active event related paradigm. Neurocase: Case Studies in Neuropsychology, Neuropsychiatry and Behavioural Neurology, 25, 1-7. doi:10.1080/13554790902724904

Hustinx, R. (April 2008). PET/CT in gastrointestinal tumors : fast technological changes lead to improved patient management. PET Clinics, 3. doi:10.1016/j.cpet.2008.11.001

Hustinx, R., Witvrouw, N., & Tancredi, T. (April 2008). Liver metastases. PET Clinics, 3, 187-195. doi:10.1016/j.cpet.2008.09.004

Boly, M., Phillips, C., Tshibanda, L., Vanhaudenhuyse, A., Schabus, M., Dang Vu, T. T., Moonen, G., Hustinx, R., Maquet, P., & Laureys, S. (2008). Intrinsic brain activity in altered states of consciousness: how conscious is the default mode of brain function? Annals of the New York Academy of Sciences, 1129, 119-29. doi:10.1196/annals.1417.015

Coucke, P., Barthelemy, N., Hustinx, R., & Fillet, G. (2008). Risk adaptive treatment in Hodgkin's lympoma: reduction of radiation dose and irradiated volume. Belgian Journal of Medical Oncology, 2 (2), 85-97.

Duysinx, B., Corhay, J.-L., Larock, M.-P., Nguyen Dang, D., Bury, T., Hustinx, R., & Louis, R. (2008). Prognostic value of metabolic imaging in non-small cell lung cancers with neoplasic pleural effusion. Nuclear Medicine Communications, 29 (11), 982-6. doi:10.1097/MNM.0b013e32830978c4

Duysinx, B., Corhay, J.-L., Larock, M.-P., Withofs, N., Bury, T., Hustinx, R., & Louis, R. (2008). Apport de l'imagerie par tomographie a emission de positons dans la pathologie pleurale. Interet de la TEP en pathologie pleurale. Revue des Maladies Respiratoires, 25 (2), 129-38. doi:10.1016/S0761-8425(08)71511-0

Gosseries, O., Demertzi, A., Noirhomme, Q., Tshibanda, J., Boly, M., de Beeck, M. O., Hustinx, R., Maquet, P., Salmon, E., Moonen, G., Luxen, A., Laureys, S., & De Tiege, X. (2008). Que mesure la neuro-imagerie fonctionnelle: IRMf, TEP & MEG? Revue Médicale de Liège, 63 (5-6), 231-7.

Hustinx, R., Jerusalem, G., & De Prijck, B. (2008). Tomographie à émission de positons et lymphomes. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 32, 449-455. doi:10.1016/j.mednuc.2008.06.002

Knuuti, J., & Hustinx, R. (2008). Highlights of the annual congress of the European Association of Nuclear Medicine, Copenhagen 2007. European Journal of Nuclear Medicine and Molecular Imaging, 35 (3), 655-72. doi:10.1007/s00259-007-0674-0

LOVINFOSSE, P., BORN, J., MARTIN, D., LEMAIRE, C., AERTS, J., & HUSTINX, R. (2008). Evaluation of primary brain tumors with F-TYR and FDG PET : correlation with pathology and survival. Journal of Nuclear Medicine, 49 (SUPPL), 77.

NAMUR, G., KAISER, M.-J., Deprez, M., MALAISE, M., & HUSTINX, R. (2008). Is FDG-PET/CT an early indicator of the clinical response to rituximab in rheumatoid arthritis ? Journal of Nuclear Medicine, 49 (SUPPL), 10.

Sakalihasan, N., Hustinx, R., Gomez, P., & Limet, R. (2008). Functional imaging of abdominal aortic aneurysms. In Aortic Aneurysms, new insights of an old problem (pp. 395-406). Liège, Belgium: Editions de l’ULg.

Sakalihasan, N., Hustinx, R., Gomez, P., & Limet, R. (2008). Can Positron Emission Tomography (PET) predict the risk of rupture of abdominal aortic aneurysm(AAA)? In Controversies and updates in vascular surgery 2008 (pp. 15-22). Torino, Italy: Ed. Minerva Medica.

SAKALIHASAN, N., HUSTINX, R., GOMEZ, P., NCHIMI LONGANG, A., & LIMET, R. (2008). Can positron emission tomography (PET) predict the risk of rupture of abdominal aortic aneurysm (AAA) ? Controversies and updates in vascular surgery. In Can positron emission tomography (PET) predict the risk of rupture of abdominal aortic aneurysm (AAA) ? Controversies and updates in vascular surgery. Italy: Edizioni Minerva Medica.

Sanjurjo, S., Hamida, W., Letesson, G., Hustinx, R., Gillet, P., & Andrianne, R. (2008). Repérage scintigraphique préopératoire d'une métastase costale unique d'un adénocarcinome prostatique opéré. Progrès en Urologie, 18 (6), 402-5. doi:10.1016/j.purol.2008.03.006

Schnakers, C., Hustinx, R., Vandewalle, G., Majerus, S., Moonen, G., Boly, M., Vanhaudenhuyse, A., Bruno, M.-A., & Laureys, S. (2008). Measuring the effect of amantadine in chronic anoxic minimally conscious state. Brain Injury. doi:10.1136/jnnp.2007.124099

Schnakers, C., Hustinx, R., Vandewalle, G., Majerus, S., Moonen, G., Boly, M., Vanhaudenhuyse, A., & Laureys, S. (2008). Measuring the effect of amantadine in chronic anoxic minimally conscious state. Journal of Neurology, Neurosurgery and Psychiatry, 79 (2), 225-7. doi:10.1136/jnnp.2007.124099

WITHOFS, N., GRAYET, B., Tancredi, T., RORIVE, A., BECKERS, C., JERUSALEM, G., & HUSTINX, R. (2008). PET/CT for assessing bone involvement in prostate and breast cancer. Journal of Nuclear Medicine, 49 (SUPPL), 21.

Witvrouw, N., De Prijck, B., & Hustinx, R. (2008). Indications cliniques de la radiotherapie metabolique dans les lymphomes. Revue Médicale Suisse, 4 (168), 1818-22.

Louis, E., Ancion, G., Colard, A., Spote, V., Belaiche, J., & Hustinx, R. (July 2007). Noninvasive assessment of Crohn's disease intestinal lesions with F-18-FDG PET/CT. Journal of Nuclear Medicine, 48 (7), 1053-1059. doi:10.2967/jnumed.107.040436

MEDART, L., WITHOFS, N., HUSTINX, R., & DONDELINGER, R. (2007). Gossypiboma at PET-CT. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.

MEDART, L., WITHOFS, N., HUSTINX, R., & DONDELINGER, R. (2007). Another etiology for inflammatory syndrome of unknown origin. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.

NAMUR, G., VAN DAMME, H., BECKERS, C., MEDART, M., WITHOFS, N., & HUSTINX, R. (2007). FDG PET/CT for diagnostic arterial prosthetic graft infection : preliminary report. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.

Rutten, I., Cabay, J.-E., Withofs, N., Lemaire, C., Aerts, J., Baart, V., & Hustinx, R. (May 2007). PET/CT of skull base meningiomas using 2-F-18-fluoro-L-tyrosine: Initial report. Journal of Nuclear Medicine, 48 (5), 720-725. doi:10.2967/jnumed.106.038216

RUTTEN, I., CABAY, J.-E., WITHOFS, N., LEMAIRE, C., AERTS, J., BAART, V., & HUSTINX, R. (2007). PET/CT imaging of skull base meningiomas using 1-18F-fluoro-L-tyrosine; initial report. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.

Withofs, N., Salmon, E., Hallet, C., Desfontaines, P., Laureys, S., Moonen, G., & Hustinx, R. (May 2007). Effect of dementia severity and age on posterior cingulate cortex metabolism in Alzheimer's disease. Journal of Neurology, 254 (Suppl. 3), 146.

WITHOFS, N., SALMON, E., LAUREYS, S., DESFONTAINES, P., MOONEN, G., & HUSTINX, R. (2007). Voxel-based analysis of posterior cingulated cortex metabolism in Alzheimer’s disease : effect of dementia severity and age. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.

Depas, G., Decortis, T., Francotte, N., Bricteux, G., & Hustinx, R. (2007). F-18 FDG PET in infectious diseases in children. Clinical Nuclear Medicine, 32 (8), 593-8. doi:10.1097/RLU.0b013e3180a1abe8

DUYSINX, B., LAROCK, M.-P., CORHAY, J.-L., NGUYEN DANG, D., LOUIS, R., & HUSTINX, R. (2007). Prognostic value of metabolic imaging in locally advanced non small cell lung cancers. Journal of Nuclear Medicine, 48 (SUPPL), 358.

Hustinx, R., & Detry, O. (2007). Hepatobiliary disease : primary and metastatic liver tumours. In G. J. Cook, M. M. Maisey, K. Britton, & V. Chengazi (Eds.), Clinical Nuclear Medicine (Fourth Edition, pp. 661-672). New York, United States: Edward Arnold Ltd.

HUSTINX, R., SPOTE, V., ANCION, G., COLLARD, A., BELAICHE, J., & LOUIS, E. (2007). Assessment of Crohn’s disease intestinal lesions with FDG PET/CT : A prospective correlation with endoscopy. Journal of Nuclear Medicine, 48 (SUPPL), 66.

Jerusalem, G., Withofs, N., Rorive, A., & Hustinx, R. (2007). Tomographie a emission de positons: un premier bilan. Revue du Praticien, 57 (17), 1864-70.

Quatresooz, P., Hustinx, R., Franchimont, C., & Pierard, G. (2007). Le mélanome cutané dans une perspective liégeoise. Actualisation de son épidémiologie et avancées diagnostiques. Revue Médicale de Liège, 62 (Supplément), 52-S55.

Rutten, I., Cabay, J.-E., Withofs, N., Lemaire, C., Aerts, J., Baart, V., & HUSTINX, R. (2007). PET/CT imaging of skull base meningiomas using 2-18F-fluoro-L-tyrosine : Initial report. Journal of Nuclear Medicine, 48 (SUPPL), 11.

WITHOFS, N., SALMON, E., LAUREYS, S., DESFONTAINES, P., & HUSTINX, R. (2007). Voxel-based analysis of dementia severity versus age on cerebral metabolic dysfunction in Alzheimer’s disease. Journal of Nuclear Medicine, 48 (SUPPL), 172.

DUYSINX, B., Larock, M.-P., Nguyen, D., Corhay, J.-L., Bury, T., Hustinx, R., & Louis, R. (December 2006). 18f-Fdg Pet Imaging in Assessing Exudative Pleural Effusions. Nuclear Medicine Communications, 27 (12), 971-6. doi:10.1097/01.mnm.0000243366.96012.c0

Delcroix, G., Vanstraelen, G., Hustinx, R., Delvenne, P., Hayette, M.-P., Massion, P., & Canivet, J.-L. (October 2006). Pericardite aspergillaire avec tamponnade cardiaque et syndrome hemophagocytaire: un cas non classique d'immunodeficience. Revue Médicale de Liège, 61 (10), 713-8.

Seret, A., & Hustinx, R. (August 2006). Clinical applications of pinhole single photon emission tomography. Current Medical Imaging Reviews, 2 (3), 347-352. doi:10.2174/157340506777934570

Jerusalem, G., Silvestre, R., Beguin, Y., Hustinx, R., Fassotte, M.-F., & Fillet, G. (20 June 2006). FDG-PET for the routine follow-up in NHL: First prospective evaluation. Journal of Clinical Oncology, 24 (18, Part 1 Suppl. S), 439.

Beckers, C., Jeukens, X., Ribbens, C., Andre, B., Marcelis, S., Leclercq, P., Kaiser, M.-J., Willems, J., Hustinx, R., & Malaise, M. (March 2006). F-18-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. European Journal of Nuclear Medicine and Molecular Imaging, 33 (3), 275-280. doi:10.1007/s00259-005-1952-3

Belhocine, T., Pierard, G., Frühling, J., Letesson, G., Bolle, S., Hustinx, R., Dargent, J.-L., Flamen, P., & Rigo, P. (2006). Clinical added-value of 18FDG PET in neuroendocrine-merkel cell carcinoma. Oncology Reports, 16 (2), 347-352. doi:10.3892/or.16.2.347

Couturier, O., Jerusalem, G., N'Guyen, J.-M., & Hustinx, R. (2006). Sequential positron emission tomography using [18F]fluorodeoxyglucose for monitoring response to chemotherapy in metastatic breast cancer. Clinical Cancer Research, 12 (21), 6437-43. doi:10.1158/1078-0432.CCR-06-0383

Heymans, O., Fallais, C., & Hustinx, R. (2006). Intratissular Lymphaticovenous Anastomoses Demonstrated by Perioperative Intramuscular Injection of 99mtc-Colloids. Lymphatic Research and Biology, 4 (1, Spring), 29-33. doi:10.1089/lrb.2006.4.29

Hustinx, R., & Malaise, M. (2006). PET imaging of arthritis. PET Clinics, 1, 131-139. doi:10.1016/j.cpet.2006.02.003

Jerusalem, G., & Hustinx, R. (2006). The lymphomas. Nuclear Medicine. In G. P. Canellos, A. T. Lister, & B. Young, The lymphomas (pp. 189-202). Philadelphia, United States: Saunders.

Jerusalem, G., Hustinx, R., & Rigo, P. (2006). PET and PET/CT imaging in lymphomas. In P. E. Valk, D. Delbeke, D. L. Bailey, D. W. Townsend, & M. N. Maisey, Positron emission tomography (pp. 125-145). Londres, United Kingdom: Springer.

Jerusalem, G., Rorive, A., Ancion, G., Hustinx, R., & Fillet, G. (2006). Diagnostic and therapeutic management of carcinoma of unknown primary: radio-imaging investigations. Annals of Oncology, 17 Suppl 10, 168-76. doi:10.1093/annonc/mdl255

Laret, V., Sion, C., Bataille, C., Hustinx, R., & Reginster, M. (2006). Le cas clinique du mois. Colite a clostridium difficile. Revue Médicale de Liège, 61 (11), 750-2.

Rigo, P., Hustinx, R., & Bury, T. (2006). PET imaging in lung cancer. In P. E. Valk, D. Delbeke, D. L. Bailey, D. W. Townsend, & M. M. Maisey (Eds.), Positron emission tomography (pp. 89-106). Londres, United Kingdom: Springer.

Rigo, P., Hustinx, R., & Bury, T. (2006). PET and PET/CT Imaging in Lung Cancer. In P. Valk, D. Delbeke, D. Bailey, D. Townsend, & M. Maisey (Eds.), Positron Emission Tomography - Clnical practice (pp. 89-106). Springer.

Zhuang, H., Hustinx, R., & Alavi, A. (2006). Effect of diazepam on the efficacy of dual-phase FDG PET imaging. European Journal of Nuclear Medicine and Molecular Imaging, 33 (2), 228-9; author reply 230. doi:10.1007/s00259-005-1957-y

Couturier, O., Léost, F., Campone, M., Carlier, T., Chatal, J.-F., & Hustinx, R. (September 2005). Is 3 '-deoxy-3 '-[F-18] fluorothymidine ([F-18]-FLT) the next tracer for routine clinical PET after R [F-18]-FDG? Bulletin du Cancer, 92 (9), 789-798.

Defawe, O. D., Hustinx, R., Defraigne, J.-O., Limet, R., & Sakalihasan, N. (May 2005). Distribution of F-18 fluorodeoxyglucose (F-18 FDG) in abdominal aortic aneurysm: High accumulation in macrophages seen on PET Imaging and immunohistology. Clinical Nuclear Medicine, 30 (5), 340-341. doi:10.1097/01.rlu.0000159681.24833.95

Ancion, G., Foidart-Willems, J., Willems, V., & Hustinx, R. (2005). L'image du mois. Mise en evidence d'une metastase intracanalaire rachidienne d'un carcinome pulmonaire par TEP/TDM. Revue Médicale de Liège, 60 (7-8, Jul-Aug), 637-8.

BECKERS, C., BERNARD, C., KAISER, M.-J., RIBBENS, C., MALAISE, M., & HUSTINX, R. (2005). Time-course study of (F-18)-FDG uptake in psoriatic synovitis. Journal of Nuclear Medicine, 46 (SUPPL), 183.

Couturier, O., Leost, F., Campone, M., Carlier, T., Chatal, J.-F., & Hustinx, R. (2005). La 3'-deoxy-3'-[18F] fluorothymidine ([18F]-FLT) est-elle le prochain traceur utilise en routine pour la TEP apres le [18F]-FDG? Bulletin du Cancer, 92 (9), 789-98.

Depas, G., De Barsy, C., Jerusalem, G., Hoyoux, C., DRESSE, M.-F., Fassotte, M.-F., Paquet, N., Willems, J., Rigo, P., & Hustinx, R. (January 2005). F-18-FDG PET in children with lymphomas. European Journal of Nuclear Medicine and Molecular Imaging, 32 (1), 31-38. doi:10.1007/s00259-004-1604-z

HEYMANS, FALLAIS, C., & HUSTINX, R. (2005). Intratissular lymphaticovenous anastomoses demonstrated by preoperative injection of 99mTc colloids. Journal of Nuclear Medicine, 46 (SUPPL), 326.

Hustinx, R., Pourdehnad, M., Kaschten, B., & Alavi, A. (January 2005). PET imaging for differentiating recurrent brain tumor from radiation necrosis. Radiologic Clinics of North America, 43 (1), 35-47. doi:10.1016/j.rcl.2004.09.009

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Whole-Body Positron Emission Tomography using 18F-Fluorodeoxyglucose for Staging Response Assessment in Hodgkin's Disease. In B. C. Heinz (Ed.), Trends in Hodgkin's Disease Research (pp. 169-188). New York, United States: Nova Science Publishers.

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Positron emission tomography imaging for lymphoma. Current Opinion in Oncology, 17 (5), 441-5. doi:10.1097/01.cco.0000174041.29557.5c

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Evaluation of therapy for lymphoma. Seminars in Nuclear Medicine, 35 (3), 186-96. doi:10.1053/j.semnuclmed.2005.02.004

LAROCK, M.-P., DUYSINX, B., NGUYEN, D., CORHAY, J.-L., BURY, T., LOUIS, R., & HUSTINX, R. (2005). FDG-PET imaging for assessing pleural malignancy : a semi-quantitative analysis. Journal of Nuclear Medicine, 46 (SUPPL), 426.

LETESSON, G., FOIDART-WILLEMS, J., & HUSTINX, R. (2005). FDG-PET imaging for diagnosing bone infection. Journal of Nuclear Medicine, 46 (SUPPL), 323.

Hustinx, R. (November 2004). PET imaging in assessing gastrointestinal tumors [letter to the editor]. Radiologic Clinics of North America, 42 (6), 1123. doi:10.1016/j.rcl.2004.08.003

Couturier, O., Chatal, J.-F., & Hustinx, R. (September 2004). Fluorinated analogs of nucleosides and fluorinated tracers of gene expression for positron emission tomography. Bulletin du Cancer, 91 (9), 695-703.

Couturier, O., Luxen, A., Chatal, J.-F., Vuillez, J.-P., Rigo, P., & Hustinx, R. (August 2004). Fluorinated tracers for imaging cancer with positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging, 31 (8), 1182-1206. doi:10.1007/s00259-004-1607-9

Beckers, C., Ribbens, C., Andre, B., Marcelis, S., Kaye, O., Mathy, L., KAISER, M.-J., Hustinx, R., Willems, J., & Malaise, M. (June 2004). Assessment of disease activity in rheumatoid arthritis with 18F-FDG PET. Journal of Nuclear Medicine, 45 (6), 956-964.

Sakalihasan, N., Hustinx, R., & Limet, R. (June 2004). Contribution of Pet Scanning to the Evaluation of Abdominal Aortic Aneurysm. Seminars in Vascular Surgery, 17 (2), 144-53. doi:10.1053/j.semvascsurg.2004.03.002

Paquet, N., Albert, A., Willems, J., & Hustinx, R. (May 2004). Within-patient variability of F-18-FDG: Standardized uptake values in normal tissues. Journal of Nuclear Medicine, 45 (5), 784-788.

Couturier, O., Bodet-Milin, C., Cherel, M., & Hustinx, R. (2004). Traceurs fluorés de la prolifération des cancers en tomographie par émission de positons. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 28 (8), 371-376.

Couturier, O., Hustinx, R., & Chatal, J.-F. (2004). New strategies and new impact of cancer imaging. In J. SERVIER (Ed.), Cancer : recent evidence, innovative strategies, future promises (pp. 98-104). Paris, France: Elsevier.

Kaschten, B., Lemaire, C., Luxen, A., Stevenaert, A., & HUSTINX, R. (2004). 18F-tyrosine PET in Neurooncology : an alternative to 11C-methionine. Journal of Nuclear Medicine, 45 (SUPPL), 264.

Rigo, P., Hustinx, R., & Bury, T. (2004). PET in lung cancer. In D. L. Bailey, D. W. Townsend, P. E. Valk, & M. N. Maisey, Positron emission tomography. Principles and practice (pp. 517-534). Springer.

Jerusalem, G., & Hustinx, R. (15 October 2003). Tomographie a emission de positons: une revolution en cancerologie? Revue du Praticien, 53 (15), 1629-30.

Alberini, J. L., Belhocine, T., Hustinx, R., Daenen, F., & Rigo, P. (October 2003). Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome). Nuclear Medicine Communications, 24 (10), 1081-1086. doi:10.1097/00006231-200310000-00008

Belhocine, T., Blockmans, D., Hustinx, R., Vandevivere, J., & Mortelmans, L. (September 2003). Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data [letter to the editor]. European Journal of Nuclear Medicine and Molecular Imaging, 30 (9), 1305-1313. doi:10.1007/s00259-003-1209-y

Belhocine, T., Kridelka, F., Thille, A., De Barsy, C., Foidart-Willems, J., Hustinx, R., & Rigo, P. (June 2003). Staging of primary cervical cancers: the role of nuclear medicine [letter to the editor]. Critical Reviews in Oncology/Hematology, 46 (3), 275-284. doi:10.1016/S1040-8428(03)00027-1

Bénard, F., Romsa, J., & Hustinx, R. (April 2003). Imaging gliomas with positron emission tomography and single-photon emission computed tomography [letter to the editor]. Seminars in Nuclear Medicine, 33 (2), 148-162. doi:10.1053/snuc.2003.127304

Hustinx, R., Lemaire, C., Jerusalem, G., Moreau, P., Cataldo, D., Duysinx, B., Aerts, J., Fassotte, M.-F., Foidart, J., & Luxen, A. (April 2003). Whole-body tumor imaging using PET and 2-18F-fluoro-l-tyrosine: Preliminary evaluation and comparison with 18F-FDG. Journal of Nuclear Medicine, 44 (4), 533-539.

BELHOCINE, T., THILLE, A., DE BARSY, C., KRIDELKA, F., HUSTINX, R., & FOIDART-WILLEMS, J. (2003). Added value of whole body 18FDG PET imaging in monitoring uterine cancers. European Journal of Nuclear Medicine and Molecular Imaging, 30 (SUPPL 2), 269.

DE BARSY, DEPAS, G., DRESSE, M.-F., HOYOUX, C., SCHMITZ, V., JERUSALEM, G., FASSOTTE, M.-F., FOIDART-WILLEMS, J., & HUSTINX, R. (2003). Whole-body FDG PET in the follow-up of pediatric patients with lymphoma. Journal of Nuclear Medicine, 44, 346.

DE BARSY, DEPAS, G., DRESSE, M.-F., HOYOUX, C., SCHMITZ, V., JERUSALEM, G., FASSOTTE, M.-F., FOIDART-WILLEMS, J., & HUSTINX, R. (2003). Whole-body FDG PET imaging as a method for staging and early assessment of treatment response in pediatric patients with lymphoma. Journal of Nuclear Medicine, 44, 183.

Hustinx, R. (2003). Tomographie à émission de positons : vers une approche plus spécifique des pathologies oncologiques. Unpublished post doctoral thesis (Agrégation de l'enseignement supérieur), ULiège - Université de Liège.
Jury: Rigo, P. (Promotor).

Hustinx, R., & Alavi, A. (2003). Tumor imaging. In C. S. Redvanly & M. J. Welch (Ed.), Handbook of Radiopharmaceuticals. Radiochemistry and Applications (pp. 629-642). Chichester, United Kingdom: John Wiley & Sons.

Hustinx, R., & Paulus, P. (2003). Radiothérapie métabolique des douleurs osseuses d'origine métastatique : nouveaux traitements, nouvelles pratiques. Annalen van de Belgische Vereniging voor Stralingsbescherming, 28, 9-20.

Hustinx, R., Sautois, B., Jerusalem, G., & Foidart, J. (2003). Radiothérapie métabolique des douleurs osseuses métastatiques. Médecine et Hygiène, 61, 1560-1564.

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Belhocine, T., Hustinx, R., Rigo, P., & Fillet, G. (2003). Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Annals of Oncology, 14 (1), 123-30. doi:10.1093/annonc/mdg011

Jerusalem, G., Hustinx, R., Beguin, Y., Depas, G., Fassotte, M.-F., De Barsy, C., Foidart, J., & Fillet, G. (2003). Les lymphomes. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 27 (8), 401-410.

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2003). PET scan imaging in oncology. European Journal of Cancer, 39 (11), 1525-34. doi:10.1016/S0959-8049(03)00374-5

PAQUET, N., HUSTINX, R., & FOIDART-WILLEMS, J. (2003). Intra-patient variability of SUV in normal tissues. European Journal of Nuclear Medicine and Molecular Imaging, 30 (SUPPL 2), 327.

PAQUET, N., LEFEBVRE, B., HUSTINX, R., FORTIN, A., & CAMIRE, M. (2003). Value of 18FDG gamma camera coincidence imaging in the follow-up of head and neck squamous cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging, 30 (SUPPL 2), 278.

Paquet, P., Hustinx, R., Rigo, P., & Pierard, G. (2003). Malignant melanoma. In P. Oehr, H. J. Biersack, & E. R. Coleman (Eds.), PET and PET-CT in Oncology (pp. 259-265). Heidelberg, Germany: Srpinger.

Belhocine, T., De Barsy, C., Hustinx, R., & Willems-Foidart, J. (September 2002). Usefulness of F-18-FDG PET in the post-therapy surveillance of endometrial carcinoma. European Journal of Nuclear Medicine and Molecular Imaging, 29 (9), 1132-1139. doi:10.1007/s00259-002-0878-2

Belhocine, T., Steinmetz, N., Hustinx, R., Bartsch, P., Jerusalem, G., Seidel, L., Rigo, P., & Green, A. (September 2002). Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clinical Cancer Research, 8 (9), 2766-2774.

Belhocine, T., Willems, J., Rigo, P., Najjar, F., Thiry, A., Quatresooz, P., & Hustinx, R. (August 2002). Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67. Nuclear Medicine Communications, 23 (8), 727-734. doi:10.1097/00006231-200208000-00005

BECKERS, C., RIBBENS, C., ANDRE, B., MARCELLIS, M., KAYE, O., RIGO, P., HUSTINX, R., FOIDART-WILLEMS, J., & MALAISE, M. (2002). FDG-PET imaging for monitoring rheumatoid arthritis treated by infliximab injections. Journal of Nuclear Medicine, 43, 38.

BECKERS, C., RIBBENS, C., ANDRE, B., MARCELLIS, M., KAYE, O., RIGO, P., HUSTINX, R., FOIDART-WILLEMS, J., & MALAISE, M. (2002). Characterization of inflamed joints in rheumatoid arthritis patients using FDG-PET: correlation with clinical and ultrasonographical assessment. Journal of Nuclear Medicine, 43, 38.

Belhocine, T., Kaye, O., Delanaye, P., Corman, V., Baghaie, M., Deprez, M., Daenen, F., De Barsy, C., Beckers, C., Gomez, P., Hustinx, R., Foidart-Willems, J., Demonty, J., Malaise, M., & Rigo, P. (2002). Maladie de Horton et atteintes arterielles extratemporales: utilite de la tomographie par emission de positons au 18FDG. A propos de trois observations et d'une revue de la litterature. Revue de Médecine Interne, 23 (7), 584-91. doi:10.1016/S0248-8663(02)00620-3

DE BARSY, C., DAENEN, F., BENARD, F., & HUSTINX, R. (2002). Is FDG bowel uptake modified by oral spasmolytic premedication ? Journal of Nuclear Medicine, 43, 203.

Hustinx, R., Bénard, F., & Alavi, A. (January 2002). Whole-body FDG-PET imaging in the management of patients with cancer [letter to the editor]. Seminars in Nuclear Medicine, 32 (1), 35-46. doi:10.1053/snuc.2002.29272

HUSTINX, R., Lemaire, C., JERUSALEM, G., MOREAU, P., Cataldo, D., DUYSINX, B., Aerts, J., & Luxen, A. (2002). 18F-fluoro-L-tyrosine : a potential tracer for whole-body tumor imaging with PET. Journal of Nuclear Medicine, 43, 77.

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2002). The value of positron emission tomography (PET) imaging in disease staging and therapy assessment. Annals of Oncology, 13 Suppl 4, 227-34. doi:10.1093/annonc/mdf664

Malaise, M., Kaye, O., Radermecker, M., Duysinx, B., Hustinx, R., Hermans, G., & de Leval, L. (2002). Une dorsalgie malheureusement tenace. Revue Médicale de Liège, 57 (5), 270-273.

Warland, V., Jerusalem, G., Hustinx, R., Beguin, Y., Silvestre, R. M., Fassotte, M.-F., Foidart, J., & Fillet, G. (2002). Comment etablir le bilan de fin de traitement des patients atteints de lymphomes non-hodgkiniens (LNH) de malignite intermediaire ou elevee? Revue Médicale de Liège, 57 (12), 779-84.

Najjar, F., Hustinx, R., Jerusalem, G., Fillet, G., & Rigo, P. (August 2001). Positron Emission Tomography (PET) for Staging Low-Grade Non-Hodgkin's Lymphomas (NHL). Cancer Biotherapy and Radiopharmaceuticals, 16 (4), 297-304. doi:10.1089/108497801753131372

Albérini, J.-L., Belhocine, T., Daenen, F., Hustinx, R., & Rigo, P. (2001). Apport de la tomographie par émission de positons pour la détection des tumeurs primitives lors de la découverte de métastases. Bulletin du Cancer, 88 (5), 518-519.

BECKERS, C., HUSTINX, R., FOIDART-WILLEMS, J., RIGO, P., & MALAISE, M. (2001). Glucose metabolism in rheumatoid arthritis knee joints before and after anti-TNF-apha blockade : evaluation by PET with 18-FDG. IN PROCEEDINGS ANNUAL AMI MEETING 2001, P56.

BELHOCINE, T., HUSTINX, R., GIELEN, J.-L., DAENEN, F., DE BARSY, C., de LA BRASSINNE, M., PIERARD, G., LAHAYE, T., & RIGO, P. (2001). Usefulness of sentinel node biopsy and FDG PET imaging in loco-regional lymph node staging of malignant melanoma. Journal of Nuclear Medicine, 42, 298.

BELHOCINE, T., HUSTINX, R., KRIDELKA, F., THILLE, A., DAENEN, F., DE BARSY, C., & RIGO, P. (2001). Usefulness of FDG-PET imaging in the management of cervical carcinoma. Journal of Nuclear Medicine, 42, 286.

Hustinx, R., Shiue, C. Y., Alavi, A., McDonald, D., Shiue, G. G., Zhuang, H., Lanuti, M., Lambright, E., Karp, J. S., & Eck, S. L. (January 2001). Imaging in Vivo Herpes Simplex Virus Thymidine Kinase Gene Transfer to Tumour-Bearing Rodents Using Positron Emission Tomography And. European Journal of Nuclear Medicine, 28 (1), 5-12. doi:10.1007/s002590000396

Jerusalem, G., Beguin, Y., Najjar, F., Hustinx, R., Fassotte, M.-F., Rigo, P., & Fillet, G. (2001). Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Annals of Oncology, 12 (6), 825-30. doi:10.1023/A:1011169332265

Jerusalem, G., Belhocine, T., Silvestre, R.-M., Sautois, B., Hustinx, R., Beguin, Y., Fillet, G., & Rigo, P. (2001). Place de la tomographie d'émission de positons dans le suivi thérapeutique du cancer du sein. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 25 (6), 341-346.

Shiue, G. G., Shiue, C.-Y., Lee, R. L., MacDonald, D., Hustinx, R., Eck, S. L., & Alavi, A. (2001). A simplified one-pot synthesis of 9-[(3-[18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine([18F]FHPG) and 9-(4-[18F]fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG) for gene therapy. Nuclear Medicine and Biology, 28 (7), 875-83. doi:10.1016/S0969-8051(01)00253-0

Daenen, F., Hustinx, R., Belhocine, T., Focan, C., Honore, P., & Rigo, P. (February 2000). Tomographie a emission de positons au 18FDG et adenocarcinome pancreatique. Revue Médicale de Liège, 55 (2), 89-94.

Belhocine, T., Hustinx, R., Devillers, C., Daenen, F., Beckers, C., Paulus, D., & Rigo, P. (2000). PET for carcinomas of the genitourinary system. In I. Khakhali, J. Laublant, & S. J. Goldsmith, NUCLEAR ONCOLOGY : DIAGNOSIS AND THERAPY (pp. 403-416). Londres, United Kingdom: Lippincott Williams and Wilkins.

BELHOCINE, T., HUSTINX, R., JERUSALEM, G., FASSOTTE, M.-F., DUYSINX, B., QUADEN, C., & RIGO, P. (2000). 99mTc rh-Annexin V (ApomateTM) as a marker of apoptosis resulting from chemotherapy : preliminary results. Journal of Nuclear Medicine, 41 (SUPPL), 263.

BENARD, F., SMITH, R., ALAVI, A., VERREAULT, J., HUSTINX, R., & MATTHIES, A. (2000). Relationship between camera physical characteristics and clinical performance of patient studies: an evaluation of two dedicated PET systems. Journal of Nuclear Medicine, 41 (SUPPL), 180.

Bhatnagar, A., Hustinx, R., & Alavi, A. (2000). Nuclear imaging methods for non-invasive drug monitoring. Advanced Drug Delivery Reviews, 41 (1), 41-54. doi:10.1016/S0169-409X(99)00055-1

Evans, S. M., Kachur, A. V., Shiue, C. Y., Hustinx, R., Jenkins, W. T., Shive, G. G., Karp, J. S., Alavi, A., Lord, E. M., Dolbier, W. R. J., & Koch, C. J. (2000). Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1. Journal of Nuclear Medicine, 41 (2), 327-36.

HUSTINX, R. (2000). Intérêt de la tomographie à émission de positons au FDG dans les néoplasies colorectales et hépatiques: aspects cliniques et méthodologiques. Unpublished doctoral thesis, ULiège - Université de Liège.
Jury: .

Hustinx, R., Dolin, R. J., Benard, F., Bhatnagar, A., Chakraborty, D., Smith, R. J., Jang, S., & Alavi, A. (2000). Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis. European Journal of Nuclear Medicine, 27 (9), 1365-71. doi:10.1007/s002590000287

HUSTINX, R., SHIUE, C., ZHUANG, H., MCDONALD, D., LANUTI, M., LAMBRIGHT, E., SHIUE, G., SMITH, G., KARP, J., LU, P., ECK, S., & ALAVI, A. (2000). Imaging in vivo herpes simplex virus thymidine kinase gene transfer and expression in tumors using positron emission tomography. Journal of Nuclear Medicine, 41 (SUPPL), 264.

JERUSALEM, G., BEGUIN, Y., FASSOTTE, M.-F., BELHOCINE, T., HUSTINX, R., RIGO, P., & FILLET, G. (2000). Early detection of relapse by whole-body positron emission tomography (PET) using 18F-fluorodeoxyglucose (18F-FDG) in the follow-up of patients with Hodgkin’s disease (HD). PROCEEDINGS OF AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING 2000, 19, 10.

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Belhocine, T., Najjar, F., Hustinx, R., Rigo, P., & Fillet, G. (2000). Evaluation thérapeutique précoce par tomographie à émission de positons. Médecine et Hygiène, 58, 1629-1632.

NAJJAR, F., HUSTINX, R., JERUSALEM, G., FILLET, G., & RIGO, P. (2000). Whole-body 18FDG-PET for staging low grade non Hodgkin’s lymphoma. European Journal of Nuclear Medicine, 27, 1159.

Paquet, P., Henry, F., Belhocine, T., Hustinx, R., Najjar, F., Pierard-Franchimont, C., Pierard, G., & Rigo, P. (2000). An Appraisal of 18-Fluorodeoxyglucose Positron Emission Tomography for Melanoma Staging. Dermatology, 200 (2), 167-9. doi:10.1159/000018357

Rigo, P., Belhocine, T., Hustinx, R., & Foidart, J. (2000). TEP et tumeurs endocrines. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 24 (5), 275-282.

SMITH, R., BENARD, F., HUSTINX, R., & ALAVI, A. (2000). Measured attenuation correction in whole-body PET : essential and simple. European Journal of Nuclear Medicine, 27, 1000.

SMITH, R., MATTHIES, A., HUSTINX, R., & ALAVI, A. (2000). The value and limitations of SUV measurements and method to enhance their utility. European Journal of Nuclear Medicine, 27, 1002.

Hustinx, R., Paulus, P., Daenen, F., Detroz, B., Honore, P., Comhair, N., & Rigo, P. (December 1999). Intérêt de la tomographie a émission de positons dans l'évaluation des tumeurs digestives. Revue Médicale de Liège, 54 (12), 925-30.

Hustinx, R., Paulus, P., Daenen, F., Detroz, B., Honore, P., Comhair, N., & Rigo, P. (March 1999). Interet clinique de la tomographie a emission de positons dans la detection et le bilan d'extension des recidives des cancers colorectaux. Gastroentérologie Clinique et Biologique, 23 (3), 323-9.

Benard, F., Smith, R. J., Hustinx, R., Karp, J. S., & Alavi, A. (1999). Clinical evaluation of processing techniques for attenuation correction with 137Cs in whole-body PET imaging. Journal of Nuclear Medicine, 40 (8), 1257-63.

DUARTE, P., HUSTINX, R., COUTURIER, O., SMITH, R., & ALAVI, A. (1999). Hottest pixel analysis: Useful value or statistical artifact ? Journal of Nuclear Medicine, 40, 292.

Hustinx, R., & Alavi, A. (1999). SPECT and PET imaging of brain tumors. Neuroimaging Clinics of North America, 9 (4), 751-66.

HUSTINX, R., DOLIN, R., BENARD, F., BHATNAGAR, A., SMITH, R., JANG, S., & ALAVI, A. (1999). Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: An ROC analysis. Journal of Nuclear Medicine, 40, 139.

Hustinx, R., Eck, S. L., & Alavi, A. (1999). Potential applications of PET imaging in developing novel cancer therapies. Journal of Nuclear Medicine, 40 (6), 995-1002.

HUSTINX, R., EVANS, S., KACHUR, C., SHIUE, C., JENKINS, W., SHIUE, G., KARP, J., LORD, E., DOLBIER, R., ALAVI, A., & KOCH, C. (1999). Non-invasive assessment of tumor hypoxia with the 2-nitroimidazole 18F-EF1 and PET. Journal of Nuclear Medicine, 40, 99.

Hustinx, R., Smith, R. J., Benard, F., Bhatnagar, A., & Alavi, A. (1999). Can the standardized uptake value characterize primary brain tumors on FDG-PET? European Journal of Nuclear Medicine, 26 (11), 1501-9. doi:10.1007/s002590050487

Hustinx, R., Smith, R. J., Benard, F., Rosenthal, D. I., Machtay, M., Farber, L. A., & Alavi, A. (1999). Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. European Journal of Nuclear Medicine, 26 (10), 1345-8. doi:10.1007/s002590050593

HUSTINX, R., SMITH, R., ROSENTHAL, D., & ALAVI, A. (1999). Dual time-point FDG-PET imaging to distinguish tumor from normal and inflammatory sites in the head and neck. Journal of Nuclear Medicine, 40, 237.

POURDEHNAD, M., DUARTE, P., OKPAKU, S., HUSTINX, R., & ALAVI, A. (1999). Adverse effects of edema on adjacent gray matter function in patients with brain tumor as determined by FDG-PET imaging. Journal of Nuclear Medicine, 40, 112.

Rigo, P., Albérini, J.-L., Hustinx, R., Paulus, P., Baretto, A., & Daenen, F. (1999). Intérêt de la tomographie à émission de positons dans l'évaluation des tumeurs gastro-intestinales. Acta Endoscopica, 29 (2), 129-138.

SHIUE, C., SHIUE, G., HUSTINX, R., ALAVI, A., & ECK, S. (1999). An improved synthesis of 9-[(3)-[F-18]fluoro-1-hydroxy-2-propoxy)methyl]guanine ([F-18]FHPG). Journal of Nuclear Medicine, 40, 83.

SMITH, R., HUSTINX, R., ADAM, L., & KARP, J. (1999). Clinical performance of the C-PET camera. Journal of Nuclear Medicine, 40, 280.

Paulus, P., Sambon, A., Vivegnis, D., Hustinx, R., Moreau, P., Collignon, J., Deneufbourg, J.-M., & Rigo, P. (October 1998). 18fdg-Pet for the Assessment of Primary Head and Neck Tumors: Clinical, Computed Tomography, and Histopathological Correlation in 38 Patients. Laryngoscope, 108 (10), 1578-83. doi:10.1097/00005537-199810000-00029

Paquet, P., Hustinx, R., Rigo, P., & Pierard, G. (February 1998). Malignant Melanoma Staging Using Whole-Body Positron Emission Tomography. Melanoma Research, 8 (1), 59-62. doi:10.1097/00008390-199802000-00010

BHATNAGAR, A., HUSTINX, R., SHNIER, D., KILROY, K., BENARD, F., & ALAVI, A. (1998). Stomach uptake in FDG PET scans: is it related to blood glucose level ? Journal of Nuclear Medicine, 39, 126P-127.

HUSTINX, R., BENARD, F., SHNIER, D., SMITH, R., & ALAVI, A. (1998). Can standardized uptake value (SUV) characterize brain tumors on FDG PET Scan ? Journal of Nuclear Medicine, 39, 164P-165.

HUSTINX, R., HACKNEY, D., BENARD, F., ALAVI, J., ECK, S., JUDY, K., PHILIPS, P., & ALAVI, A. (1998). Evaluation of response to gene therapy for malignant gliomas with FDG PET imaging and MRI. Journal of Nuclear Medicine, 39, 255.

Hustinx, R., Paulus, P., Jacquet, N., Jerusalem, G., Bury, T., & Rigo, P. (1998). Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases. Annals of Oncology, 9 (4), 397-401. doi:10.1023/A:1008290027419

Palmedo, H., Biersack, H. J., Lastoria, S., Maublant, J., Prats, E., Stegner, H. E., Bourgeois, P., Hustinx, R., Hilson, A. J., & Bischof-Delaloye, A. (1998). Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial. European Journal of Nuclear Medicine, 25 (4), 375-85. doi:10.1007/s002590050235

Bury, T., Dowlati, A., Paulus, P., Corhay, J.-L., Hustinx, R., Ghaye, B., Radermecker, M., & Rigo, P. (November 1997). Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer. European Respiratory Journal, 10 (11), 2529-34. doi:10.1183/09031936.97.10112529

HUSTINX, R., PAULUS, P., BURY, T., CATALDO, D., RIGO, P., & FOIDART-WILLEMS, J. (1997). Efficacy of Tc-99m P829, a radiolabelled somatostatin analog in visualising mediastinal spread of non-small cell lung cancer. European Journal of Nuclear Medicine, 24, 959.

HUSTINX, R., PAULUS, P., JACQUET, N., & RIGO, P. (1997). Whole-body FDG-PET as a firstline procedure for detection and staging of recurrent rectal or digmoid carcinoma: preliminary results. European Journal of Nuclear Medicine, 24, 882.

PAULUS, P., HENRY, S., HUSTINX, R., & RIGO, P. (1997). Improved head and neck FDG-PET imaging using segmented attenuation correction. European Journal of Nuclear Medicine, 24, 936.

Paulus, P., Hustinx, R., Daenen, F., Comhair, N., & Rigo, P. (1997). Usefulness of 18fdg Positron Emission Tomography in Detection and Follow-up of Digestive Cancers. Acta Gastro-Enterologica Belgica, 60 (4, Oct-Dec), 278-80.

PAULUS, P., SAMBON, A., HUSTINX, R., SERVILLE, M.-N., MOREAU, P., & RIGO, P. (1997). Use of positron emission tomography with 18 FDG in patients with head and neck cancers. Clinical usefulness to recurrence detection and staging of lymph node involvement. European Journal of Nuclear Medicine, 24, 996.

PAULUS, P., VIVEGNIS, D., SAMBON, A., HUSTINX, R., MOREAU, P., & RIGO, P. (1997). Rôle de la TEP au 18FDG dans le bilan d'extension ganglionnaire et la détection des récidives des cancers de la tête et du cou. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 21, 347.

Rigo, P., Paulus, P., Bury, T., Jerusalem, G., Hustinx, R., Benoit, T., Larock, M.-P., & Foidart, J. (1997). Clinical PET in oncology. Radioactive Isotopes in Clinical Medicine Research XXII.

Rigo, P., Paulus, P., Bury, T., Jerusalem, G., Hustinx, R., Benoit, T., Larock, M.-P., & Willems, J. (1997). Clinical PET in Oncology. In H. Bergmann, A. Kroiss, & Sinzinger H (Eds.), Radioactive Isotopes in Clinical Medicine and Research (pp. 3-14). Basel, Switzerland: Birhauser Verlag.

Rigo, P., Paulus, P., Kaschten, B., Hustinx, R., Bury, T., Jerusalem, G., Benoit, T., & Foidart-Willems, J. (December 1996). Oncological Applications of Positron Emission Tomography with Fluorine-18 Fluorodeoxyglucose. European Journal of Nuclear Medicine, 23 (12), 1641-74. doi:10.1007/BF01249629

DAENEN, F., HUSTINX, R., PAULUS, P., DEMEZ, P., JACQUET, N., & RIGO, P. (May 1996). Detection of recurrent colorectal carcinoma with whole-body FDG-PET. Journal of Nuclear Medicine, 37, 261.

HUSTINX, R., PAULUS, P., DAENEN, F., JERUSALEM, G., JACQUET, N., & RIGO, P. (May 1996). PET imaging of liver metastases: a retrospective study. Journal of Nuclear Medicine, 37, 250P-251.

Bury, T., Paulus, P., Weber, T., Hustinx, R., Corhay, J.-L., Rigo, P., & Radermecker, M. (April 1996). Comment j'explore ... une suspicion de cancer broncho-pulmonaire par tomographie a émission de positrons. Revue Médicale de Liège, 51 (4), 317-9.

Bury, T., Dowlati, A., Paulus, P., Hustinx, R., Radermecker, M., & Rigo, P. (February 1996). Staging of Non-Small-Cell Lung Cancer by Whole-Body Fluorine-18 Deoxyglucose Positron Emission Tomography. European Journal of Nuclear Medicine, 23 (2), 204-6. doi:10.1007/BF01731846

Hustinx, R., Paulus, D., Rigo, P., Yeung, H. W., Macapinlac, H. A., & Larson, S. M. (1996). Clinical PET in Oncology. France: GE Medical Systems.

HUSTINX, R., PAULUS, P., BENOIT, T., JERUSALEM, G., JACQUET, N., & RIGO, P. (1996). Clinical value of whole body-body PET-FDG in the detection of liver metastases: preliminary results. European Journal of Nuclear Medicine, 23, 1110.

PAULUS, P., BURY, T., HUSTINX, R., DOWLATI, A., & RIGO, P. (1996). Comparison of positron emission tomography and computed tomography in the mediastinal and extrathoracic staging of non-small cell lung cancer. Journal of Nuclear Medicine, 37, 260.

PAULUS, P., HUSTINX, R., BURY, T., RADERMECKER, M., & RIGO, P. (1996). FDG-PET and lung cancer: evaluation of solitary pulmonary nodule and mediastinal staging. Proceedings of the VIIth International PET Conference, Institute for Clinical PET.

Hustinx, R., Verloes, A., Grattagliano, B., Herens, C., Jamar, M., Soyeur, D., Schaaps, J.-P., & Koulischer, L. (01 September 1993). Monosomy 11q: Report of Two Familial Cases and Review of the Literature. American Journal of Medical Genetics, 47 (3), 312-7. doi:10.1002/ajmg.1320470303